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CHAPTER I 
INTRODUCTION 
The Helicobacter pylori cag Type IV Secretion System 
Helicobacter pylori is a Gram-negative bacterium that colonizes the 
stomach in about half of the world’s population (1, 2).  Persistent H. pylori infection 
is a risk factor for the development of gastric cancer or peptic ulcer disease, and 
has been designated a Class I carcinogen by the World Health Organization (3, 4). 
Adverse disease outcomes associated with H. pylori infection occur predominantly 
in persons infected with strains that produce an effector protein known as CagA, 
which is translocated into host cells by a type IV secretion system (T4SS) (5-7). 
The cagA gene and genes required for T4SS-dependent secretion of CagA are 
located within a 40-kb region of the H. pylori chromosome known as the cag 
pathogenicity island (cag PAI) (5, 6).  The cag PAI is a 40 kb region of the H. pylori 
genome that is present in almost 100% of East Asian strains and 60-70% of 
strains isolated from western countries (5, 8, 9).  The CagA effector protein 
contributes to both the carcinogenesis and ulcer development associated with H. 
pylori by exerting a variety of effects within the host cell (10, 11). Upon entry into 
host cells, CagA causes alterations in cell signaling that are linked to gastric 
carcinogenesis. Src family kinases phosphorylate the C-terminus of CagA, and 
once phosphorylated, CagA alters the function of a variety of host proteins.  One of 
these is the oncoprotein SHP2, which upon activation by CagA initiates a signaling 
cascade resulting in the activation of the Erk MAPK pathway, causing unregulated 
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cell growth (12, 13).  CagA is the only protein known to be secreted by the H. 
pylori cag T4SS. The T4SS also contributes to several phenotypes independent of 
CagA translocation. The most well-studied of these is the H. pylori induced 
stimulation of IL-8 production in gastric epithelial cells.  This is caused by 
peptidoglycan entry into host cells (14, 15) which is dependent on a fully functional 
T4SS.  
Prototypical T4SSs 
T4SSs are a versatile family of secretion systems found in a wide variety of 
bacterial species, not just H. pylori (16-18). Three main functional categories of 
T4SSs are recognized: those that deliver effector proteins into host cells, those 
that export DNA, and those that import DNA (18). Effector proteins or DNA-protein 
complexes can be delivered into many types of recipient cells, including 
mammalian cells, plant cells, fungi, or other bacteria. Examples of DNA-
translocating T4SSs include the VirB/D system found in Agrobacterium 
tumefaciens (which translocates T-DNA into plant cells, causing crown-gall 
disease) and plasmid conjugation systems (such as the Escherichia coli pKM101-
encoded Tra system). Effector protein-translocating T4SSs are exemplified by the 
Dot/Icm systems in Legionella and Coxiella, and the H. pylori cag T4SS.  
The system initially used characterize T4SSs is the VirB/VirD system 
present in A. tumefaciens (19).  In the paradigm set by this system the T4SS 
machinery is intricate and involves three main protein subassemblies.  First is the 
core complex (16, 20, 21), a large group of physically interacting proteins that span 
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the inner and outer membrane of the bacterium and is predicted to anchor the 
pilus.  Second is the energy subcomplex, which is a group of ATPases responsible 
for providing energy for substrate translocation and formation of the rest of the 
T4SS machinery (22, 23).  The final group is composed of the subunits that form 
the structure of the pilus, which forms when the bacteria come into contact with 
host cells(19). This pilus then can be used to translocate effector molecules into 
the host cell.   
There are twelve proteins responsible for the proper formation and function 
of the T4SS in A. tumefaciens (24).  In contrast, there are fifteen proteins encoded 
in the H. pylori cag PAI which are essential for activity of the cag T4SS, since they 
were indispensable for IL-8 induction (14).   Interestingly, there are also three Cag 
proteins that are dispensable for IL-8 induction, but are required for CagA 
translocation, implying that there are multiple steps in CagA translocation that 
require more than functional T4SS machinery (14).  
Differences between prototypical T4SSs and the cag T4SS 
Some of cag proteins are predicted to be homologous to A. tumefaciens 
counterparts.  However, most of these predictions are strictly based on sequence 
similarity, protein predictions and localization.  A recent model proposed H. pylori’s 
core complex is made of CagT, X, and Y, the ATPases are CagE, α, and β and the 
pilus is made of major pilin subunit, CagC and minor subunit, CagL (24, 
25).  However, these connections are tenuous at best.  For example, CagY has 
only a 32% protein sequence similarity to its A. tumefaciens counterpart.  CagC, 
the proposed major pilin subunit can be knocked out without abrogating pilus 
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formation (26).  CagT is 208 amino acids long, as opposed to 50 in its A. 
tumefaciens counterpart.  Finally, CagM and Cag3, two H. pylori proteins required 
for T4SS activity, have no homologous counterparts in A. 
tumefaciens.  Furthermore, nine of the cag PAI genes required for CagA 
translocation are unique to H. pylori with no obvious homologs in other bacteria. 
This suggests that there are important differences between the H. pylori cag T4SS 
and T4SSs in other bacterial species. Multiple models for the structural 
organization of the H. pylori cag T4SS have been proposed, but there are 
numerous limitations and controversial features of the current models, due to a 
lack of detailed biochemical and structural data 
One of those cag proteins which were required for CagA translocation, but 
not IL-8 induction is CagF.  This stable, soluble protein when initially characterized 
was found to physically bind and interact with the C-terminal domain of CagA (27, 
28).  However, more recent studies show that CagF binds all regions of CagA (29). 
CagF has been proposed as a chaperone for CagA, based on its low isoelectric 
point and tendency to form homodimers (28), two common characteristics of 
chaperone proteins in Type III Secretion Systems, though CagF is not required for 
CagA stability.  Since CagF is essential for CagA translocation, it is reasonable to 
presume that the CagF-CagA complex physically interacts with the cag T4SS 
machinery.  However, no studies have detected any interactions between CagA, 
CagF and the cag T4SS machinery.   
Structural characterization of T4SSs from multiple species 
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While A. tumefaciens provided the basic model of T4SSs, the most detailed 
structural work has been done in E. coli. The E. coli T4SS are utilized for 
conjugation and thus somewhat different than the A. tumefaciens effector molecule 
translocating system.   
The first major subassembly of the T4SS that was described in detail was 
the core complex.  In 2009 the Waksman group overexpressed the core complex 
components from the pKM101 plasmid (VirB7/TraN, VirB9/TraO, VirB10/TraF) and 
tagged the C-terminus of VirB10/TraF with a Strep tag (a small affinity tag), thus 
allowing for the selective purification of the core complex (16, 21).  They were able 
to obtain a 15 Å cryoEM structure of the entire core complex (16), and a 2.6Å 
crystal structure of the upper “O-layer” of the core complex (21).  These studies 
revealed the pKM101 core complex to be a large membrane-spanning channel 
with two chambers, a 14-fold symmetry and 18.5 nm in diameter.  This group went 
on to employ a similar purification method but this time overexpressing the 
proteins VirB3-10 (VirB3/TrwM, VirB4/TrwK, VirB5/TrwJ,VirB6/TrwI, VirB7/TrwH, 
VirB8/TrwG, VirB9/TrwF and VirB10/TrwE) from the R388 conjugation plasmid 
(30).  They were able to obtain a low-resolution, negative stain structure of this 
entire subassembly (30).  These studies recapitulated their findings about the core 
complex, and went on to characterize the inner membrane complex (IMC) of the 
R388 T4SS.  The IMC is composed of VirB3, 4, 5, 6, and 8, with a stalk-like 
domain connecting the core complex with the large barrel-like assemblies of the 
VirB4 ATPases (30). 
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Recently there has been work on characterization of a different T4SS core 
complex, namely the core complex from the Dot/Icm system in Legionella 
pneumophila.  In contrast to the E. coli pKM101 and R388 systems the Dot/Icm 
T4SS used for effector protein translocation rather than bacterial conjugation. The 
publication reported the use of an approach that did not utilize affinity purifications 
to isolate T4SS subassemblies, but instead utilized differential centrifugation to 
isolate the core complex of the Dot/ICM T4SS (31).  This study found that the core 
complex was composed of five proteins, DotG, H, C, F, and D. DotF corresponds 
to VirB10, DotH corresponds to VirB9 and DotD corresponds to VirB7, while DotC 
and G are specific to Legionella.  The Dot/Icm core complex is far larger than the 
core complex of the E. coli conjugation system, about 38 nm in diameter rather 
than 18.5nm (31).  However, is it also ring-like and contains a central channel.  Its 
symmetry remains unknown, and thus cannot be compared to E. coli’s.  
There is clearly a large body of work describing T4SSs and their role in 
bacterial pathogenesis.  However, T4SSs present in various bacterial species 
have a wide range of function and there is a high level of divergence among 
species in both composition of the systems and sequences of components. In 
particular the literature on the cag T4SS system is relatively sparse and therefore it 
is important to learn more about such an understudied and biologically relevant 
system. 
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CHAPTER II 
ISOLATION OF A cag T4SS SUBASSEMBLY 
Introduction 
The cag T4SS is an important virulence factor present in large percentage 
of H. pylori strains. The cag T4SS is responsible for translocating the effector 
protein, CagA into the gastric epithelium.  CagA itself is a bona fide oncoprotein 
(32). Transgenic mice engineered to constitutively express CagA developed 
tumors (33).  Furthermore, epidemiological studies have shown that strains 
containing genes encoding the cag T4SS are correlated with severe disease 
outcomes (11).  These results indicate that the cag T4SS is a significant virulence 
factor with a broad impact on public health.  
Because of its relevance to public health, there has been a lot of interest in 
elucidating the architecture and the molecular mechanisms which regulate the cag 
T4SS.  There has been a large body of work on other model systems such as E. 
coli to study and develop a basic model of how the T4SS functions, but the cag 
T4SS appears to be quite divergent from these prototypical systems.  Only the two 
Cag proteins encoding the ATPase subunits (CagE and Cagα)  and the coupling 
protein (Cagβ) have any significant level of sequence similarity with the model 
systems, and those major subunits tend to be the most highly conserved proteins 
of this machinery (24, 25).  But even that similarity breaks down since CagE 
appears to be a fusion of the two prototypical ATPases, VirB3 and 
VirB4.  Furthermore, most prototypical T4SSs require 12 proteins, whereas the 
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cag PAI encodes 27, clearly showing that this system is far more complex and 
different than other model systems.   
The Cover lab has attempted to isolate subassemblies of the T4SS by using 
the same tagging strategies employed by the Waksman group, but to date these 
studies have not been successful.  We have tagged other proteins that are integral 
members of the T4SS as determined by a requirement of these proteins for CagA 
translocation and IL-8 induction in an attempt to find another way to isolate 
components of the cag T4SS.  To date we have tagged CagM, 3, X, V,  H, I, L, U 
using the HA epitope tag.  By tagging either CagH, I, or L, we were able to 
determine that these three proteins directly interacted with one another and they 
they were involved in pilus formation or regulation.  However, the complex itself 
was never directly studied.  The other proteins tagged did not yield protein 
complexes. 
I decided to take an alternative and indirect approach to purify components 
of the cag T4SS.  CagA is an intriguing candidate for this method: since CagA is 
translocated through the T4SS, a logical conclusion would be that it would 
physically interact with the T4SS.  However, putting tags on this protein often 
abrogates its ability to translocate, meaning that it is likely no longer interacting 
with the T4SS.  But there are also other proteins that interact with CagA which 
could then still take advantage of CagA’s potential interaction with the cag 
T4SS.  One such protein is CagF, which has been referred to as CagA’s 
“chaperone” (27, 28).  This protein is highly expressed and localized to both the 
cytosol and inner membrane of H. pylori.  It has been called a chaperone since it is 
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required for the translocation of CagA and it has been confirmed as a binding 
partner of CagA. My hopes were that CagF could act as a “handle” of sorts, to 
purify larger complexes of the cag T4SS. 
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Materials and Methods 
Bacterial strains and culture methods 
Wild-type H. pylori strain 26695 and mutant strains were cultured on 
trypticase soy agar plates supplemented with 5% sheep blood, or on Brucella agar 
plates supplemented with 10% heat-inactivated fetal bovine serum (FBS), in room 
air supplemented with 5% CO2. H. pylori mutant strains were selected in the 
presence of chloramphenicol (2.5 μg/mL), metronidazole (7.5 μg/mL), or 
streptomycin (50 μg/mL). Liquid cultures of H. pylori were grown in Brucella broth 
supplemented with 10% heat-inactivated FBS. E. coli strain DH5α was used for 
plasmid propagation and was grown on either Luria-Bertani (LB) agar plates or in 
LB broth supplemented with ampicillin (100 μg/mL). 
Cell culture methods 
AGS human gastric epithelial cells were grown in RPMI media 
supplemented with 10% FBS, 2 mM glutamine and 10 mM HEPES. 
Generation of H. pylori strains producing HA-tagged CagF 
To generate H. pylori strains producing HA-tagged forms of CagF, we first 
constructed the plasmids illustrated in Fig. 1a. These plasmids are modified forms 
of the pAD-1 plasmid (26, 34) that contain a full length copy of the cagF gene 
(along with sequences encoding an HA-epitope tag at the N-terminus or C-
terminus of CagF), the ureA promoter and ribosomal binding site (RBS), and a 
chloramphenicol resistance cassette. These elements are flanked by sequences 
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from the ureA and ureB loci (26, 34). H. pylori strain 26695 or mutant strains were 
transformed with these plasmids (which do not replicate in H. pylori) and 
chloramphenicol-resistant transformants were selected. This approach allowed the 
introduction of sequences encoding HA-tagged CagF into the H. pylori ureAB 
chromosomal locus. H. pylori strains designated HA-CagF and CagF-HA produce 
CagF with N-terminal or C-terminal HA tags, respectively. 
Isolation of the H. pylori cag T4SS core complex 
H. pylori strains were grown in liquid culture for 16 h (resulting in values of 
optical density at 600 nm [OD600] of 0.4 to 0.8). Bacterial cells were pelleted at 
3,300 × g for 15 min at 4°C and resuspended in radioimmunoprecipitation assay 
(RIPA) buffer (1% NP-40, 0.25% deoxycholate, 10 mM HEPES, and 100 mM NaCl 
[pH 7.0] supplemented with 1 mM phenylmethylsulfonyl fluoride [PMSF] and 
protease inhibitors [Complete Mini Protease Inhibitor tablet; Roche]) for initial 
experiments or in RIPA buffer containing 300 mM NaCl for experiments involving 
electron microscopy and density gradients. The bacterial suspensions were 
sonicated on ice and incubated for 1 h at 4°C, and the bacterial lysates were then 
centrifuged (21,000 × g) to pellet insoluble material. Monoclonal anti-HA antibodies 
were noncovalently linked to protein G Dynabeads (Invitrogen) and incubated with 
the clarified bacterial lysates at room temperature for 30 min. Beads were washed 
three times at room temperature with the same buffers used for bacterial lysis, and 
proteins were selectively eluted with wash buffer containing 200 µg/ml HA peptide 
(YPYDVPDYA; GenScript). To isolate the core complex from H. pylori cocultured 
with gastric epithelial cells, subconfluent AGS cells were cocultured with H. pylori 
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(multiplicity of infection [MOI] of 100) for 4 h. After rinsing with phosphate-buffered 
saline (PBS) to remove nonadherent bacteria, adherent bacteria and epithelial 
cells were resuspended in RIPA buffer, and the protocol described above was 
used. 
Analysis of IL-8 secretion 
AGS human gastric epithelial cells were grown in RPMI medium (Corning) 
supplemented with 10% FBS, 2 mM glutamine and 10 mM HEPES and co-cultured 
with H. pylori strains at a multiplicity of infection (MOI) of 50 for four hours.  IL-8 
secretion was quantified using an anti-human IL-8 sandwich ELISA (R&D) (26, 
34). 
Western blotting 
Proteins were separated on a 10% acrylamide gel, transferred to a 
nitrocellulose membrane, and immunoblotted using previously described rabbit 
polyclonal antisera to H. pylori Cag proteins (26), or antiserum to CagF that was 
generated by immunizing animals with a CagF-GST fusion protein. Horseradish 
peroxidase conjugated to anti-rabbit IgG (Promega) was used as a secondary 
antibody. Signals were generated by an enhanced chemiluminescent reaction and 
detected using x-ray film. 
Silver stain 
Proteins were separated on a 10% acrylamide gel and then stained using 
Pierce’s silverstain kit. 
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Mass spectrometry analysis 
Protein preparations were either run about 2 cm into a 10% Bis-Tris 
NuPAGE gel, stained with Colloidal Coomassie, and then subjected to in-gel 
trypsin digestion, or TCA-precipitated. For the latter, precipitated proteins were 
resolubilized in a solution of 8M urea, 100 mM Tris, pH 8.5, reduced with Tris(2-
carboxyethyl)phosphine (TCEP, 10 mM), and alkylated with iodoacetamide (20 
mM).  Samples were then diluted back to 2M urea, trypsin added and allowed to 
digest overnight at 37oC. Single dimensional LC-MS/MS was performed using 
ThermoFisher LTQ equipped with a nano-electrospray source and attached to an 
Eksigent 1D+ or Nanoacuity (Waters) HPLC unit with an autosampler. Peptides 
were resolved via reversed phase separation on a 20 cm by 100 micron column 
packed emitter tip using an aqueous to organic gradient (2% to 45%). Peptide 
MS/MS spectra were acquired data-dependently with one full scan MS followed by 
5 MS/MS scans.  MudPITs were performed essentially as described previously (3, 
4). Acidified peptides were loaded onto a 150 micron ID biphasic trapping column 
comprised of 4 cm strong cation exchange resin (LUNA 5 micron, Phenomonex) 
followed by 4 cm reverse phase resin (Jupiter 5 micron, 300 angstrom). The 
trapping column was then attached to a 20 cm (Jupiter 3 micron, 300 angstrom) 
100 micron ID fused silica analytical column packed into a pulled nanospray tip. 
Preparations of eluted proteins and respective WT controls were analyzed by 8-
step MudPIT. Salt pulses were performed by using the autosampler to inject 5 ul of 
ammonium acetate at 0, 100, 150, 200, 300, 500, 750, and 1000 mM 
concentrations. After each salt injection, peptides were separated using a 105 
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minute aqueous to organic gradient (2% to 35% acetonitrile (ACN) for all but the 
last step, which went to 98% ACN). Peptide MS/MS spectra were queried using 
SEQUEST (full tryptic specificity) against an H. pylori strain 26695 database, to 
which both common contaminants and reversed versions of the proteins had been 
appended. Resulting identifications were filtered to an estimated peptide false 
discovery rate (FDR) less than 5% and collated by protein using IDPicker 3.0. All 
reported proteins were identified based on detecting a minimum of 2 distinct 
peptides. 
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Results 
Purification of CagF and co-purification of additional Cag proteins 
Previous studies have shown that the H. pylori CagA effector protein 
interacts with another cag PAI-encoded protein, CagF (28, 29, 35). CagF is 
required for CagA translocation into eukaryotic host cells, and it has been 
proposed that CagF is a chaperone for CagA (28, 29, 35). We hypothesized that 
the CagF-CagA complex physically interacts with components of the cag T4SS 
machinery and that the CagF-CagA complex could be used as bait for purifying 
subassemblies of the cag T4SS. To test this hypothesis, we generated three H. 
pylori strains that produced hemagglutinin (HA) epitope-tagged forms of CagF; two 
(HA-CagF and ΔcagF/HA-CagF) produced CagF with an N-terminal tag, and one 
(CagF-HA) produced CagF with a C-terminal tag (Fig. 1a and b) The HA-CagF 
and CagF-HA strains retained the endogenous cagF gene (encoding an untagged 
form of CagF), whereas the ΔcagF/HA-CagF strain encoded only the tagged form 
of CagF. All three strains retained the ability to induce IL-8 secretion in human 
gastric epithelial (AGS) cells, indicating that the cag T4SS is functional in each of 
these strains (Fig. 1c). 
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Figure 1: Generation of H. pylori strains that produce HA-tagged CagF. (a) 
Schematic of plasmids encoding epitope-tagged forms of CagF (with either an N-
terminal or C-terminal epitope HA tag). The sequences were introduced into the H. 
pylori ureAB chromosomal locus, yielding strains designated HA-CagF or CagF-
HA, respectively. The HA-CagF and Cag-HA strains retained the endogenous 
cagF gene (encoding an untagged form of CagF). We also generated a ΔcagF/HA-
CagF strain, which encodes only the tagged form of CagF. In this strain, the 
endogenous copy of cagF was deleted, and a gene encoding HA-CagF was 
introduced into the urease locus. (b) Immunoblotting of the indicated strains with 
an anti-HA antibody showed the production of HA-tagged forms of CagF. (c) AGS 
cells were infected with the wild-type (WT) strain or the indicated strains producing 
HA-tagged CagF, and IL-8 production was quantified by ELISA. AGS indicates 
results for cells without added H. pylori. Values represent means ± SD, based on 
analysis of at least six replicate samples. Levels of IL-8 production induced by 
mutant strains were compared to levels induced by the WT strain (ANOVA 
followed by Dunn’s multiple-comparison test). *, P < 0.001. (d) SDS-PAGE and 
silver stain analysis of preparations immunopurified from strains producing HA-
tagged CagF (using a monoclonal HA antibody) and analysis of a control 
preparation from an untagged WT strain that was processed in parallel. 
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We immunopurified HA-tagged CagF from lysates of the three H. pylori 
strains using a monoclonal HA antibody, and an untagged wild-type (WT) strain 
was processed in parallel as a negative control. SDS-PAGE and silver stain 
analyses showed distinct proteins in preparations derived from the strains 
producing HA-tagged CagF that were absent in preparations from the untagged 
WT control strain (Fig. 1d). Immunoblotting showed that CagF and CagA were 
immunopurified from the strains producing HA-tagged CagF, whereas neither of 
these proteins was immunopurified from the untagged WT control strain (Fig. 2). 
We then immunoblotted the samples with a panel of antibodies against several 
components of the cag T4SS and found that Cag3, CagT, CagM, CagX, and CagY 
copurified with CagF and CagA (Fig. 2). Since similar results were obtained with 
all three strains producing HA-tagged CagF (Fig. 2), we conducted subsequent 
experiments using strains producing CagF with an N-terminal HA tag (either HA-
CagF or ΔcagF/HA-CagF). 
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Figure 2: Analysis of proteins that copurify with CagF. Immunoblot analysis of 
preparations immunopurified from three strains producing HA-tagged CagF using 
a monoclonal HA antibody and of a control preparation from an untagged WT 
strain that was processed in parallel. Samples were immunoblotted with the 
indicated antisera. Results are representative of at least two independent 
experiments. 
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Analysis by mass spectrometry indicated that the seven Cag proteins 
described above (CagF, CagA, Cag3, CagT, CagM, CagX, and CagY) were the 
most abundant proteins in preparations derived from the HA-CagF-producing 
strain and that each of these proteins was enriched in preparations from the HA-
CagF-producing strain compared to a control preparation from the untagged WT 
strain (Table 1). The copurification of several H. pylori proteins encoded by genes 
outside the cag PAI and produced at high levels by the bacteria (Table 1) most 
likely reflects nonspecific interactions. 
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Table 1: Proteins that co-purify with HA-CagF 
Identified Proteins 
Accession 
Number 
Spectral Counts (HA-CagFa) 
Spectral Counts 
(WTa) 
CagA HP0547 178 0 
CagF HP0543 56 1 
CagX HP0528 40 0 
CagM HP0537 38 0 
Cag3 HP0522 44 0 
CagT HP0532 26 0 
CagY HP0527 18 0 
Protease HP1350 28 0 
VacA HP0887 16 8 
GroEL HP0010 12 0 
Omp18 HP1125 6 0 
EF-Tu HP1205 5 1 
hypothetical protein HP0052 1 7 
FrpB HP0876 1 7 
Total Cag Spectra  400 1 
Total Non-Cag Spectra  69 23 
Total Spectra  469 24 
aHA-CagF was immunoaffinity purified from an H. pylori strain expressing this 
protein using a monoclonal anti-HA antibody, and a wild-type strain (WT)  was 
processed in parallel as a control. The table shows numbers of spectral counts 
detected in each preparation by Multidimensional Protein Identification Technology 
(MudPIT). 
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Purification of CagF in co-culture with gastric epithelial cells 
The immunopurifications described above were performed using lysates of 
H. pylori grown in liquid culture. CagA is not actively secreted by the bacteria 
under such conditions, but H. pylori contact with gastric epithelial cells triggers 
translocation of CagA into the epithelial cells (12, 36). We hypothesized that H. 
pylori contact with gastric epithelial cells leads to activation of the cag T4SS, 
possibly resulting in altered interactions of the CagF-CagA complex with T4SS 
components. Therefore, we cocultured AGS gastric epithelial cells with HA-CagF-
producing H. pylori (ΔcagF/HA-CagF) and purified HA-CagF from lysates of the 
coculture. AGS cells cocultured with untagged WT bacteria were processed in 
parallel as a negative control. Mass spectrometry analysis revealed that 
preparations isolated from the coculture contained the same seven Cag proteins 
detected in the earlier experiments (Table 2). Low levels of several other Cag 
proteins were also detected (Table 2). Importantly, Cag3, CagT, CagM, CagX, and 
CagY reproducibly co-purified with CagF and CagA in experiments conducted with 
either bacterial cell-epithelial cell co-cultures or bacterial liquid cultures. 
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Table 2: Proteins that co-purify with HA-CagF when H. pylori ΔcagF/HA-CagF 
is co-cultured with AGS cells 
Identified Proteins 
Accessio
n 
Number 
Assigned 
Spectral 
Counts ( 
ΔcagF/HA-
CagFa) 
Assigned 
Spectral 
Counts 
(WTa) 
cag pathogenicity island protein Cag3 HP0522 58 0 
cag pathogenicity island protein CagY HP0527 165 1 
cag pathogenicity island protein CagX HP0528 86 0 
cag pathogenicity island protein CagW HP0529 2 1 
cag pathogenicity island protein CagV HP0530 7 0 
cag pathogenicity island protein CagT HP0532 36 0 
cag pathogenicity island protein CagM HP0537 50 0 
cag pathogenicity island protein CagL HP0539 2 0 
cag pathogenicity island protein CagI HP0540 3 0 
cag pathogenicity island protein CagG HP0542 3 1 
cag pathogenicity island protein CagF HP0543 51 2 
cag pathogenicity island protein CagE HP0544 12 0 
cag pathogenicity island protein CagA HP0547 882 11 
chaperone and heat shock protein (groEL)  HP0010 23 16 
co-chaperone (groES)  HP0011 2 0 
outer membrane protein (omp2)  HP0025 5 3 
citrate synthase (gltA)  HP0026 13 3 
urease accessory protein (ureG)  HP0068 3 3 
urease beta subunit (urea amidohydrolase) 
(ureB)  HP0072 2 2 
urease, alpha subunit (ureA) [3.5.1.5]  HP0073 1 3 
methyl-accepting chemotaxis transducer 
(tlpC)  HP0082 1 21 
ribosomal protein S9 (rpsI)  HP0083 2 2 
conserved hypothetical protein  HP0086 2 0 
chaperone and heat shock protein 70 (dnaK)  HP0109 4 4 
DNA topoisomerase I (topA)  HP0116 1 1 
ribosomal protein L20 (rplT)  HP0126 1 3 
hypothetical protein  HP0130 3 1 
cell binding factor 2  HP0175 6 3 
translation elongation factor EF-P (efp)  HP0177 3 0 
chaperone and heat shock protein C62.5 
(htpG)  HP0210 1 1 
peptide methionine sulfoxide reductase 
(msrA) [1.8.4.6]  HP0224 1 1 
hypothetical protein  HP0231 0 2 
ATP-dependent RNA helicase, DEAD-box HP0247 4 4 
 23  
family (deaD)  
conserved hypothetical protein  HP0248 2 1 
ATP-dependent nuclease (addB)  HP0275 2 0 
ribosomal protein L21 (rplU)  HP0296 4 3 
hypothetical protein  HP0305 4 4 
outer membrane protein (omp9)  HP0317 6 5 
conserved hypothetical protein  HP0318 2 1 
cell division inhibitor (minD)  HP0331 1 7 
adhesin-thiol peroxidase (tagD)  HP0390 5 4 
ribosomal protein S1 (rpsA)  HP0399 5 2 
oligoendopeptidase F (pepF)  HP0470 3 1 
conserved hypothetical secreted protein  HP0506 2 0 
ribosomal protein L9 (rplI)  HP0514 2 0 
transcription termination factor Rho (rho)  HP0550 3 1 
ribosomal protein L31 (rpmE)  HP0551 1 1 
acyl carrier protein (acpP)  HP0559 2 0 
3-ketoacyl-acyl carrier protein reductase 
(fabG)  HP0561 2 0 
aminopeptidase a-i (pepA)  HP0570 3 0 
ferredoxin oxidoreductase, alpha subunit  HP0589 2 2 
lipoprotein, putative  HP0596 1 1 
hemolysin secretion protein precursor (hylB)  HP0599 3 0 
tetrahydrodipicolinate N-succinyltransferase 
(dapD)  HP0626 4 1 
aspartate ammonia-lyase (aspA)  HP0649 0 2 
processing protease (ymxG)  HP0657 4 5 
N-methylhydantoinase  HP0696 1 3 
hypothetical protein  HP0720 2 0 
hypothetical protein  HP0721 5 4 
phosphoribosylpyrophosphate synthetase 
(prsA)  HP0742 1 3 
conserved hypothetical protein  HP0747 1 2 
aconitase B (acnB) [4.2.1.3]  HP0779 2 0 
preprotein translocase subunit (secA)  HP0786 3 1 
iron(III) dicitrate transport protein (fecA)  HP0807 4 0 
thioredoxin (trxA)  HP0824 5 2 
thioredoxin reductase (trxB)  HP0825 2 0 
inosine-5'-monophosphate dehydrogenase 
(guaB)  HP0829 0 2 
catalase [1.11.1.6]  HP0875 19 5 
vacuolating cytotoxin  HP0887 36 17 
hydrogenase expression-formation protein 
(hypB)  HP0900 5 0 
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outer membrane protein (omp20)  HP0912 4 1 
hypothetical protein  HP0958 2 1 
polyphosphate kinase (ppk)  HP1010 1 5 
protease (pqqE)  HP1012 4 2 
serine protease (htrA)  HP1019 6 4 
ferric uptake regulation protein (fur)  HP1027 1 2 
acetyl-CoA synthetase (acoE)  HP1045 1 1 
translation initiation factor IF-2 (infB)  HP1048 1 1 
gamma-glutamyltranspeptidase (ggt) [2.3.2.2]  HP1118 1 4 
peptidoglycan associated lipoprotein 
precursor (omp18)  HP1125 2 1 
ATP synthase F1, subunit beta (atpD)  HP1132 7 7 
ATP synthase F1, subunit alpha (atpA)  HP1134 2 3 
ribosomal protein L19 (rpl1S)  HP1147 7 5 
flavodoxin (fldA)  HP1161 10 5 
outer membrane protein (omp27)  HP1177 2 0 
carbonic anhydrase  HP1186 2 1 
translation elongation factor EF-G (fusA)  HP1195 7 0 
ribosomal protein S7 (rpsG)  HP1196 3 3 
ribosomal protein S12 (rpsL)  HP1197 0 2 
DNA-directed RNA polymerase, beta and 
beta' subunit (rpoBC)  HP1198 16 16 
ribosomal protein L7-L12 (rplL)  HP1199 2 0 
ribosomal protein L1 (rplA)  HP1201 0 2 
translation elongation factor EF-Tu (tufB)  HP1205 21 10 
DNA-directed RNA polymerase, alpha subunit 
(rpoA)  HP1293 3 1 
ribosomal protein S4 (rpsD)  HP1294 2 1 
ribosomal protein S11 (rpsK)  HP1295 0 2 
ribosomal protein S13 (rpsM)  HP1296 5 4 
ribosomal protein L15 (rplO)  HP1301 3 2 
ribosomal protein L6 (rplF)  HP1304 4 2 
ribosomal protein S8 (rpsH)  HP1305 2 2 
ribosomal protein L24 (rplX)  HP1308 0 2 
ribosomal protein L14 (rplN)  HP1309 1 1 
ribosomal protein S3 (rpsC)  HP1313 1 1 
ribosomal protein L2 (rplB)  HP1316 8 5 
ribosomal protein L3 (rplC)  HP1319 4 7 
ribosomal protein S10 (rpsJ)  HP1320 3 1 
hypothetical protein  HP1334 3 0 
protease  HP1350 11 6 
conserved hypothetical protein  HP1414 2 1 
conserved hypothetical ATP-binding protein  HP1430 5 14 
 25  
peptidyl-prolyl cis-trans isomerase B, 
cyclosporin-type rotamase (ppi)  HP1441 1 1 
gerC2 protein (gerC2)  HP1483 1 1 
iron-regulated outer membrane protein (frpB)  HP1512 2 2 
iron(III) ABC transporter, periplasmic iron-
binding protein (ceuE)  HP1561 3 1 
iron(III) ABC transporter, periplasmic iron-
binding protein (ceuE)  HP1562 4 1 
alkyl hydroperoxide reductase (tsaA)  HP1563 12 10 
outer membrane protein  HP1564 0 2 
Total Cag Spectra  1357 16 
Total Non-Cag Spectra  409 299 
Total Spectra  1766 315 
a ΔcagF/HA-CagF was immunoaffinity purified from an H. pylori strain expressing 
this protein using a monoclonal anti-HA antibody, and a wild-type strain (WT)  was 
processed in parallel as a control. The protein content of preparations was 
analyzed by Multidimensional Protein Identification Technology (MudPIT). The list 
of proteins identified was filtered via IDPicker 3.0 using a 5% peptide false 
discovery rate (FDR) and a minimum of 2 distinct peptides per protein. The table 
shows numbers of assigned spectral counts. 
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Discussion 
In this study, I isolated the putative core complex of the cag T4SS.   Our lab 
has tried to isolate large subassemblies of the cag T4SS by tagging Cag proteins 
associated with various regions of the cag T4SS.  We tagged inner membrane 
core members CagV and CagU, but were only able to purify the protein that was 
directly tagged (data not shown). We then tagged three proteins that have no 
homology to other proteins in T4SSs, Cag H, I, and L.  We were able show that 
these three proteins were interacting with one another, and involved in regulation 
or formation of the pilus, but no further efforts were made to analyze the complex 
itself.  And then finally, we tagged proteins predicted to be part of the core 
complex, Cag3, M, X, and Y.  These attempts yielded similar results to the inner 
membrane proteins: we could only isolate the tagged proteins.   
It was clear that we needed to take a different approach in purifying 
modules of the cag T4SS.  I hypothesized that we needed to use a more indirect 
approach; perhaps the affinity association with the tag was disrupting the protein-
protein interactions of this complex macromolecular machine.   One potential 
protein that could accomplish this could be CagA, the only known effector protein 
of the cag T4SS.  Since it requires the T4SS for its translocation, it has the 
potential to physically interact with the machinery, though this interaction has 
never been shown.  However, whenever our lab has tried to tag CagA, the protein 
lost its ability to be translocated.  This suggests that the tag is interfering with the 
ability of CagA to interface with the T4SS, thus making it unsuitable for my 
purposes.   
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However, there was another protein that could utilize the indirect interaction 
between CagA and the T4SS.  This protein is CagF, which is the chaperone 
protein of CagA (28, 29).  Several studies have shown that this protein physically 
interacts with CagA, and is required for CagA to be successfully translocated into 
eukaryotic cells.  Furthermore, when CagF is tagged, CagA is still translocated, 
meaning that there would be no disruption of the interaction that I sought to take 
advantage of.   
I tagged CagF with an HA (HA-CagF) epitope to enable a specific 
purification and elution from H. pylori.  I immunopurified CagF from bacterial 
lysates and was also able to isolate its cognate binding partner, the effector protein 
CagA, confirming the efficacy of my IP.  However, I was also able to isolate five 
other Cag proteins: Cag3, T, M, X and Y.  This was a specific purification, since I 
was unable to isolate any of these proteins from an untagged strain of H. 
pylori.  Those five proteins, Cag3, T, M, X, and Y correspond to the putative core 
complex of the cag T4SS.  This is the first time that the core complex has been 
purified from H. pylori, and also the first time that an interaction between the 
effector protein CagA and the cag T4SS has been observed.   
There are several assays to assess the activity of the cag T4SS.  These 
assays are grouped into two major categories: one, where the translocation of 
CagA is determined, and the other where the actual formation of the T4SS is 
assessed.   
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There are two ways to determine if CagA has been translocated.  First, 
when CagA is translocated into eukaryotic cells, it is phosphorylated by the host 
cell kinase Src (12).  Thus, an immunoblot using specific phospho-antibodies can 
be used to determine is CagA has been phosphorylated and therefore, 
translocated.  The second method is far less quantitative and relies on cell 
morphology.  When CagA is translocated into host cells, it induces actin 
cytoskeletal rearrangements, causing the cell to form long, thin protrusions.  These 
are referred to as the “hummingbird” phenotype (37).   
There are several different methods to assess formation of the 
T4SS.  These assays will still produce a positive result in the absence of CagA, 
since the cag T4SS can still form without its effector protein.  When the T4SS is 
elaborated, it is hypothesized that it requires the use of a peptidoglycan hydrolase 
(Cag4), to digest away the thin layer of peptidoglycan that exists between the inner 
and outer membrane so the pilus can be formed in the extracellular space (15).  It 
is hypothesized that this process will introduce peptidoglycan into the host cells 
when the pilus interfaces with the eukaryotic cell.  The introduction of this bacterial 
polymer will strongly induce innate immune signaling through NOD1 leading to the 
robust de-repression of the master-regulator NF-κB (15).  This gene’s upregulation 
can be detected via a reporter cell line wherein NF-κB has been fused with 
luciferase.  One of the major genes that is upregulated by this increase in NF-κB 
expression is the host cytokine, IL-8.  This provides another simple readout for cag 
T4SS function, where IL-8 production can be measured and quantified through 
ELISA. The final approach to measure cag T4SS activity is through 
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microscopy.  Utilizing SEM, the actual elaboration of the pilus structure in contact 
with eukaryotic cells can be visualized (34). 
The various assays described above show an array of diverse techniques 
that take advantage of the multitude of perturbations that the cag T4SS causes.  
However, all of these assays require the presence of eukaryotic cells and we have 
been unable to assess the functionality of the cag T4SS from pure bacterial 
culture.  The results reported here indicate that the core complex is assembled 
prior to H. pylori contact with host cells and CagA translocation. We speculate that 
CagA is bound to assembled core complexes, ready to be translocated as soon as 
the bacteria receive the appropriate signal, making the act of translocation more 
efficient.  Thus far, the molecular mechanisms that regulate CagA secretion (i.e., 
inhibition of secretion during bacterial growth in broth culture and activation of 
secretion when H. pylori contacts gastric epithelial cells) remain poorly understood.  
But these results represent an important first step in understanding them, as well 
as the first time that there has been a reported interaction between CagA and a 
major structural component of the cag T4SS.  
I also wanted to investigate the possibility that the cag T4SS might be 
reorganized when the bacteria are in contact with host cells.  To do this I 
performed my immunoprecipitation from bacteria co-cultured with gastric epithelial 
cells.  There are many other components besides the core complex that form the 
cag T4SS.  Two other major subassemblies are the ATPases which are predicted 
to form large, multimeric complexes, an inner membrane core which connects the 
core complex and the ATPases, and finally the pilus which protrudes into the 
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extracellular space.  Since the pilus is a component that only appears to form 
when the bacteria are in contact with host cells, and the ATPases are required for 
pilus formation, I hypothesized that I could purify these components from a co-
culture model.  Based on mass spec results, I purified the same seven proteins 
(CagF, A, 3, T, M, X, and Y) that I did from the experiments done in pure 
culture.  There were other Cag proteins identified in this preparation, however, 
their spectral counts were so low that is it unlikely these hits are actually 
significant.   
Overall, this is the first time that the predicted core complex of the cag 
T4SS has ever been isolated. This study is a key initial step in characterizing an 
important virulence factor of H. pylori, which has presented a considerable 
challenge to both our lab and others.  
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CHAPTER III 
COMPOSTION OF THE CORE COMPLEX 
Introduction 
In the previous chapter I showed that I could isolate the predicted members 
of the cag T4SS core complex.  The purification was a specific one and used the 
chaperone protein CagF.  The same seven proteins were isolated (CagF, A, 3, T, 
M, X, and Y) if the immunoprecipitation was performed from pure bacterial lysates 
or from H. pylori co-cultured with gastric epithelial cells.   
This result represents an important first step in defining the structure of the 
cag T4SS.  Previous studies of the core complex and subassmblies of the cag 
T4SS focused on the protein-protein interactions of the various components.  Work 
from the Cover lab in 2006 used a yeast-two-hybrid (Y2H) system to probe for 
different interactions among Cag proteins (38).  Of the predicted core complex 
proteins, they found that CagX and the C-terminus of CagY strongly interacted in a 
reciprocal manner, and to a lesser extent CagM and CagX interacted, and Cag3 
and CagT interacted.  However, a Y2H for bacteria is not a very biologically 
relevant assay since bacterial proteins are expressed in the highly 
divergent  eukaryotic system and are not localized to their normal 
compartments.  Y2H studies mainly show that proteins can interact but do not 
indicate if they do interact.   
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Several years later, this study was followed up by two more studies in 2013 
in which the interactions were assessed in H. pylori.  One study by Pinto-Santini et 
al, focusing on the protein Cag3, performed immunoprecipitations with a polyclonal 
Cag3 antibody (39).  Their work indicated that Cag3 seemed to be interacting with 
a large majority of Cag proteins, namely CagM, T, X, Y, D, 1, α, β, A, F, C, and 
E.  However, only the interactions with CagT and CagM were confirmed with 
alternative approaches; the interaction with CagT was detected with a reciprocal 
IP, and the interaction with CagM was detected with cross-linking.  It is highly likely 
that many of the other interactions could be non-specific ones due to the use of a 
polyclonal antibody. The other study was performed by Kutter et al, who reported 
IP experiments indicating that CagY interacted with CagX, CagX interacted with 
CagM and that CagM interacted with CagT.  All of those interacted were confirmed 
by reciprocal IP (35).   
These studies give a snapshot of the various protein interactions, but 
hopefully my studies of the entire protein complex can provide a more complete 
picture, instead of analyzing only one or two binding partners. Furthermore, I 
would like to be able to purify it in an alternative manner.  
In this chapter, I describe experiments deigned to study the core complex 
composition in greater detail, to determine the role that any other Cag proteins 
might have in the formation of the core complex, and to further define the protein-
protein interactions that make up the core complex itself.   
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Materials and Methods 
Isolation of the H. pylori cag T4SS core complex using a FLAG 
immunoprecipitation 
H. pylori strains were grown in liquid culture for 16 h (resulting in values of 
optical density at 600 nm [OD600] of 0.4 to 0.8). Bacterial cells were pelleted at 
3,300 × g for 15 min at 4°C and resuspended in radioimmunoprecipitation assay 
(RIPA) buffer (1% NP-40, 0.25% deoxycholate, 10 mM HEPES, and 100 mM NaCl 
[pH 7.0] supplemented with 1 mM phenylmethylsulfonyl fluoride [PMSF] and 
protease inhibitors [Complete Mini Protease Inhibitor tablet; Roche]). The bacterial 
suspensions were sonicated on ice and incubated for 1 h at 4°C, and the bacterial 
lysates were then centrifuged (21,000 × g) to pellet insoluble material. Monoclonal 
anti-FLAG antibodies were noncovalently linked to protein G Dynabeads 
(Invitrogen) and incubated with the clarified bacterial lysates at 4°C for 2 hr. Beads 
were washed three times at room temperature with the half-strength RIPA buffer, 
and proteins were selectively eluted with wash buffer containing 200 µg/ml FLAG 
peptide (DYKDDDDK; GenScript).  
Separation of proteins by gradient centrifugation 
15% and 45% solutions of glycerol were prepared in RIPA buffer containing 
300 mM NaCl.  A 15-45% 5 mL gradient was poured using a gradient mixer (Jules 
INC.). Core complex preparations isolated by immunoaffinity methods were 
applied to the top of the gradient, and the gradient was then centrifuged in a SW 
55-Ti rotor for 16 hours at 15,000 rpm at 4°C.  Fractions (each 625 μl) were 
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collected from the top of the gradient, and were subsequently analyzed by 
immunoblotting and mass spec. 
Generation of H. pylori strains producing FLAG-tagged CagT and other 
mutant strains 
Unmarked ΔcagX, Δcag3, ΔcagM, mutant strains have been described 
previously (26). Unmarked ΔcagT, ΔcagF, and ΔcagY mutant strains were 
generated using previously described contra-selection methods involving a cat-
rdxA cassette (34) or a cat-rpsL cassette (26), and a marked cagA mutant strain 
(cagA::kan) was generated by inserting a kanamycin resistance cassette. These 
mutant strains were further modified by the introduction of sequences encoding 
HA-CagF into the ureAB chromosomal locus, thereby allowing expression of CagF 
with an N-terminal HA tag. 
To make the FLAG tagged CagT construct, a point mutant were generated 
where a FLAG tag was inserted after the 27th amino acid of the protein using the 
QuikChange Multi site-directed mutagenesis kit (Agilent) and then transformed into 
a cagT::cat/rdxA strain. 
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Results 
Isolation of two distinct Cag protein complexes 
To investigate whether the proteins co-purifying with CagF were constituents of 
one or more protein complexes, we analyzed immunopurified samples prepared as 
described above by velocity sedimentation in glycerol density gradients. 
Immunoblot analysis indicated that Cag3, CagT, CagM, CagX, and CagY co-
sedimented in the bottom fractions of the gradient (i.e., in the high-molecular-mass 
fractions) (Fig. 3a). This result provides evidence that Cag3, CagT, CagM, CagX, 
and CagY are components of a large protein complex. CagA and CagF were 
detected in the first fraction (taken from the top of the gradient), separately from 
the other Cag proteins, suggesting that CagF and CagA dissociate from the larger 
complex during gradient centrifugation. Mass spectrometry analysis of the gradient 
fractions (Fig. 3b; see also Table 3) confirmed that Cag3, CagT, CagM, CagX, 
and CagY were all distributed in the same gradient fractions (supporting the 
conclusion that these are components of a protein complex), whereas CagF and 
CagA were found predominantly in fractions from the top of the gradient (Fig. 3b). 
Each of the non-Cag proteins present in the sample was detected predominantly in 
the first fraction (taken from the top of the gradient) instead of the fractions 
containing Cag3, CagT, CagM, CagX, and CagY (Fig. 3b). Thus, the stringent 
conditions of the glycerol density gradient allowed purification to homogeneity of a 
large stable complex of Cag proteins distinct from CagA, CagF, and non-Cag 
proteins (Fig. 3b; see also Table 3)   
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Figure 3: Sedimentation of H. pylori cag T4SS core complex in density 
gradients. (a) Preparations resulting from immunoaffinity purification of HA-CagF 
were analyzed by velocity sedimentation in glycerol density gradients, and gradient 
fractions (collected from the top of the gradient) were immunoblotted with the 
indicated antisera. In, input sample before it was applied to the gradient. Results 
are representative of two independent experiments. (b) The protein content of 
gradient fractions was analyzed by 1D mass spectrometry (see Table 3 for 
complete results). The distribution of CagF, CagA, Cag3, CagT, CagM, CagX, 
CagY, and total non-Cag proteins in individual gradient fractions is shown. 
  
 37  
Table 3: Protein composition of fractions resulting from the sedimentation of 
an HA-CagF-immunopurified sample in a density gradient 
 Fractions  
Identified proteins 1 2 3 4 5 6 7 8 
Total 
Assigned 
Spectra 
CagF 13 5 5 4 2 2 2 1 34 
CagA 202 104 66 32 20 11 7 2 444 
Cag3 7 4 8 15 27 21 24 6 112 
CagT 5 2 10 13 13 11 12 1 67 
CagM 1 4 6 15 18 15 16 0 75 
CagX 0 4 12 19 25 20 25 3 108 
CagY 0 7 23 38 71 62 33 16 250 
chaperone and heat shock 
protein (groEL) 
24 10 8 1 1 1 0 2 47 
protease 13 6 2 0 0 0 0 0 21 
alkyl hydroperoxide reductase 
(tsaA) 
11 4 2 0 0 0 0 0 17 
translation elongation factor 
EF-Tu (tufB) 
21 7 1 0 0 0 0 0 29 
outer membrane protein 
(omp2) 
12 0 1 1 0 0 1 1 16 
hydantoin utilization protein A 
(hyuA) 
7 1 1 0 0 1 0 1 11 
DNA-directed RNA 
polymerase, beta and beta' 
subunit (rpoBC) 
6 2 1 1 5 0 4 2 21 
superoxide dismutase (sodB) 6 3 1 2 1 0 1 0 14 
outer membrane protein 
(omp32) 
4 1 1 0 0 0 0 0 6 
excinuclease ABC subunit B 
(uvrB) 
3 0 1 0 0 0 0 1 5 
vacuolating cytotoxin 3 0 1 1 0 0 0 0 5 
S-adenosylmethionine 
synthetase 2 (metX) 
3 0 1 0 0 0 0 0 4 
hypothetical protein 1 1 1 0 0 0 0 3 6 
chaperone and heat shock 
protein 70 (dnaK) 
14 3 0 0 0 0 0 0 17 
iron-regulated outer 
membrane protein (frpB) 
13 3 0 0 0 0 0 0 16 
catalase [1.11.1.6] 11 3 0 0 0 0 0 0 14 
hypothetical protein 11 2 0 0 1 1 0 0 15 
translation elongation factor 
EF-G (fusA) 
9 1 0 1 0 0 0 1 12 
outer membrane protein 
(omp4) 
8 0 0 1 0 0 0 0 9 
adhesin-thiol peroxidase 
(tagD) 
6 2 0 0 0 0 0 0 8 
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cell binding factor 2 6 0 0 0 0 0 0 0 6 
outer membrane protein 
(omp27) 
5 0 0 0 0 0 0 0 5 
thioredoxin reductase (trxB) 5 0 0 0 0 0 0 0 5 
conserved hypothetical 
protein 
4 1 0 0 0 0 0 1 6 
lipoprotein, putative 4 0 0 0 0 0 0 0 4 
peptidoglycan associated 
lipoprotein precursor (omp18) 
3 0 0 2 3 1 1 0 10 
protective surface antigen 
D15 
3 0 0 0 0 1 0 1 5 
aminopeptidase a-i (pepA) 3 0 0 1 0 0 0 1 5 
flavodoxin (fldA) 3 1 0 1 0 0 0 0 5 
ribosomal protein L1 (rplA) 3 0 0 0 0 0 0 0 3 
ribosomal protein S1 (rpsA) 3 0 0 0 0 0 0 0 3 
outer membrane protein 
(omp20) 
3 0 0 0 0 0 0 0 3 
outer membrane protein 
(omp9) 
3 0 0 0 0 0 0 1 4 
outer membrane protein 
(omp31) 
3 0 0 0 0 0 0 0 3 
putative neuraminyllactose-
binding hemagglutinin 
homolog (hpaA) 
3 0 0 0 0 0 0 0 3 
conserved hypothetical 
secreted protein 
3 0 0 0 0 0 0 0 3 
threonyl-tRNA synthetase 
(thrS) [6.1.1.3] 
2 1 0 3 0 0 0 1 7 
ribosomal protein S3 (rpsC) 0 0 0 0 1 1 1 3 6 
 
a HA-CagF was immunoaffinity purified from an H. pylori strain expressing this 
protein using a monoclonal anti-HA antibody, and the preparation was then 
subjected to velocity sedimentation in a glycerol density gradient. The protein 
contents of gradient fractions (collected from the top of the gradient) were 
analyzed by 1-D mass spectrometry.  The numbering along the top of the table 
refers to fraction number.  The table shows numbers of spectral counts detected in 
each of the eight fractions.  
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Purification of CagT and co-purification of additional Cag proteins 
The previously described experiments indicated that through the IP of HA-
CagF I can isolate the core complex of the cag T4SS system, as well at the CagF-
CagA complex.  However, I wanted further confirmation of these results, so I 
sought out another way to purify the core complex.  Our lab has attempted to 
purify subassemblies of the cag T4SS by directly tagging proteins which are a part 
of it with llimited success.  A former labmate, Bradley Voss was attempting to 
identify surface exposed residues of CagT and thus looked for regions of low 
hydrophobicity within the protein. He identified eight regions of low hydrophobicity 
and made eight different constructs where a FLAG epitope was inserted into each 
of these regions, and then expressed the resulting FLAG-tagged forms of CagT 
from the urease locus.   
Of these eight different strains, only three retained their ability to induce IL-8 
production in gastric epithelial cells, indicating that the introduction of the FLAG 
epitope had not disrupted T4SS function.  Of these three constructs, I chose 
ΔCagT/ureA::27K (T/27KFLAG) since it had the highest basal level of CagT 
expression compared to the other two. I then immunopurified  T/27KFLAG from 
bacterial lysates. Immunoblotting showed that CagT  was immunopurified from the 
strains producing FLAG-tagged CagT, and not from the untagged WT control (Fig. 
4). I then immunoblotted the samples with a panel of antibodies against several 
components of the cag T4SS and found that Cag3, CagM, CagX, and CagY 
copurified with CagT (Fig. 4). 
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Figure 4: The FLAG-tagging of CagT allows for purification of the cag core 
complex.  Immunoblot analysis of preparations immunopurified from a strain 
producing FLAG-tagged CagT using a monoclonal FLAG antibody and of a control 
preparation from an untagged WT strain that was processed in parallel. Samples 
were immunoblotted with the indicated antisera. 
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Analysis of complexes formed by strains containing mutations in cag genes 
encoding integral components of the core complex 
We hypothesized that several of the Cag proteins identified in the 
immunopurification experiments would be required for assembly or stability of the 
core complex, whereas others would be nonessential for core complex assembly 
(despite being required for T4SS function). For example, the Cag proteins that 
have orthologs in T4SSs of multiple bacterial species are likely to be required for 
core complex formation, whereas proteins unique to H. pylori (Cag3, CagT, and 
CagM) might be dispensable. To test this hypothesis, we analyzed mutant strains 
in which cagY, cagX, cagT, cag3, and cagM were individually deleted, and each 
mutant was engineered to produce HA-CagF, thereby permitting isolation of the 
core complex. Consistent with the results of previous studies (14), these five 
mutant strains were unable to induce IL-8 secretion in AGS cells (indicating the 
absence of a functional cag T4SS) (Fig. 5a). We also generated a cagA mutant 
strain that expressed HA-CagF, and, consistent with previous results (14), this 
strain retained the capacity to induce IL-8 secretion (Fig. 5a). We then sought to 
isolate Cag protein complexes from the mutant strains by immunopurifying HA-
tagged CagF (using the method shown in Fig. 1 and 2) and analyzed the resulting 
preparations by immunoblotting. In experiments performed with ΔcagX or ΔcagY 
mutants, we successfully purified CagF and CagA but were unable to copurify core 
complex components (Fig. 5b and c), despite evidence that these proteins were 
present in lysates from these mutants (see Fig. 5c). Similarly, in an experiment 
performed with the cagA mutant strain, we successfully purified CagF but were 
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unable to copurify any components of the core complex (Fig. 5b and c). In 
contrast, we were able to immunopurify multiple Cag proteins as well as CagF and 
CagA from the Δcag3, ΔcagT, and ΔcagM mutant strains. In experiments 
performed with the Δcag3 strain, all components of the core complex (except 
Cag3) copurified with CagF and CagA. Preparations immunopurified from the 
ΔcagT strain lacked Cag3 and CagT, and preparations immunopurified from the 
ΔcagM strain lacked Cag3, CagT, and CagM (Fig. 5b and c). These experiments 
provided evidence that incomplete protein complexes can assemble in the 
absence of Cag3, CagT, or CagM (Fig.5b and c). 
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Figure 5: Immunopurification of HA-CagF from a panel of cag mutant strains. 
(a) AGS cells were cocultured with the WT strain or the indicated mutants, and IL-
8 secretion was quantified by enzyme-linked immunosorbent assay (ELISA). 
“AGS” indicates cells without added H. pylori. Values represent means ± standard 
deviations (SD), based on analysis of at least six replicate samples. Levels of IL-8 
production induced by mutant strains were compared to levels induced by the WT 
strain (analysis of variance [ANOVA] followed by Dunn’s multiple-comparison test). 
*, P < 0.001. (b) HA-CagF was immunoaffinity purified from the strains analyzed in 
panel A. The affinity-purified samples (immunopurification [IP] elution) were then 
immunoblotted with the indicated antisera. Strains are designated at the top of the 
panel, and antisera are designated at the right side of the panel. (c) Analysis of 
Cag protein production in a panel of cag mutant strains. Immunoblotting of whole-
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cell lysates from mutant strains, each expressing HA-CagF from a gene in the 
urease locus, with the indicated antisera. HspB (a GroEL heat shock protein) was 
analyzed as a loading control. Strains are designated at the top of the figure, and 
antisera are designated to the right of the figure. Arrows indicate immunoreactive 
bands corresponding to Cag proteins, and other bands correspond to cross-
reactive proteins. Two CagF bands correspond to the tagged and the untagged 
forms of the protein. (d) Summary of results from the experiments presented in 
panel B, indicating the presence or absence of Cag proteins in the preparations 
immunopurified from mutant strains. Results are representative of three 
independent experiments. 
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Discussion  
The methodology used in this study for isolating the H. pylori cag T4SS core 
complex relied on immunopurification of CagF, a cag PAI-encoded protein that 
binds the CagA effector protein (27-29). Importantly, velocity sedimentation 
experiments performed with glycerol gradients indicated that CagF and CagA are 
not integral components of the core complex. The CagF-based purification 
strategy conducted with a cagA mutant strain failed to yield core complex 
components, which suggests that CagA directly interacts with the core complex 
since CagA isn’t required for cag T4SS activity. The interaction of CagA (and 
possibly CagF) with the core complex is presumably relatively weak, as expected 
for an interaction of an effector protein with secretion machinery.  
The velocity density gradients also showed that Cag3, T, M, X, and Y also 
co-sedimented.  These five proteins are the predicted members of the core 
complex, and since they co-sedimented it shows that they form a true 
complex.  Mass spec results also showed that none of the contaminating proteins 
from the immunopurification co-sedimented with the core complex members.    
Each of the five protein components of the core complex (CagX, CagY, 
CagM, CagT, and Cag3) is required for cag T4SS-dependent phenotypes, 
including CagA translocation into host cells and induction of IL-8 secretion by 
gastric epithelial cells (14). Most of these proteins are also required for production 
of T4SS-associated pilus structures at the bacterium-host cell interface (26). 
Previous studies have localized all 5 of these proteins at the outer membrane of H. 
pylori (40, 41). CagX and CagY exhibit low-level sequence relatedness to VirB9 
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and VirB10 components of T4SSs in other bacterial species, but CagM, CagT, and 
Cag3 are not closely related to any other bacterial proteins. Sequence analysis of 
CagT suggests that it may be a lipoprotein, leading to the suggestion that it may 
be a VirB7 homolog (7). CagA exhibits a high level of sequence variation in 
comparisons of H. pylori strains from different geographic areas, but, in contrast, 
there is relatively little phylogeographic variation in sequences of the five core 
complex components (41). 
The mechanism of core complex formation in H. pylori is not at all 
understood.  In model organisms it is hypothesized that the core complex 
components form in an energy independent manner in the periplasm of the 
bacteria (19, 42).  Four of the five Cag proteins that form the core complex, (Cag3, 
T, M, and X) all have single sequences, meaning that they are transported past the 
inner membrane and into the periplasm in a Sec-dependent manner, and all of 
them are detected in the outer membrane (40).  
However, CagY does not possess a signal sequence.  That being said, this 
large protein is also present on the outer membrane and has an alpha-helical 
domain near its N-terminus that is predicted to be a transmembrane domain (35, 
43).  Therefore, CagY could be transported past the inner membrane in a Sec-
independent manner, with the predicted alpha-helical region inserting into the 
membrane.   I hypothesize that this region inserts into the inner membrane rather 
than the outer membrane, so that CagY spans from the outer membrane, through 
the periplasm and inner membrane to then reach into the cytoplasm.  Interestingly, 
the C-terminus is the region of CagY that possesses the sequence similarity with 
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VirB10, and I believe this is the part that interacts with the rest of the core complex 
components in the outer membrane.  However, the CagY N-terminus is composed 
of repeat regions and is entirely unique to H pylori (43, 44).   I hypothesize that this 
region interacts with the CagA-CagF complex, since the latter two proteins are 
localized to the cytoplasm and inner membrane, and CagY is the only component 
of the core complex that is not wholly localized to the outer 
membrane.  Furthermore, in a ΔcagY strain I can no longer isolate the core 
complex, even though components of the core complex are still present in 
bacterial lysates.  It is possible that CagY is required for the stability and formation 
of the core complex, but, it is also possible that CagY is required for the direct 
interaction of the CagA-CagF complex with the core complex. Another line of 
evidence that lends credence to the latter hypothesis is the fact that a ΔcagY strain 
can still form pili (44).  It seems highly unlikely that the pilus could still form without 
an integral structural component of the cag T4SS.  
I was also unable to isolate core complexes from a ΔcagX strain.  I believe 
that CagX is required either for the stability of the core complex or potentially as a 
nucleating factor since CagX is required for T4SS dependent phenotypes.   It 
seems unlikely that it directly interacts with CagA-CagF since CagX is solely 
localized to the outer membrane.  
Strains with either cag3, T, or M deleted still yielded partially formed 
complexes.  In a Δcag3 strain, the only protein missing from the core complex is 
Cag3, and then in the ΔcagT strain, the complex is missing Cag3 and CagT, and 
then finally in a ΔcagM strain, the core complex is missing Cag3, T and M.  This 
 48  
suggests that these three proteins directly interact with one another in a stepwise 
manner.  These proteins could potentially be on the periphery of the core complex, 
though there would need to be localization studies to confirm this theory.   
I also found another way to isolate the core complex by utilizing a FLAG tag 
on CagT.  This experiment gives the results from the CagF IP further credence, 
since CagT is an integral member of the core complex.  In future studies, this can 
also be an invaluable tool to determine the role of CagX, Y and A in core complex 
stability and formation.  I would follow the same strategy as I did in making the cag 
knock-out strains that could express HA-CagF, though instead of using HA-CagF I 
would use T/27KFLAG, and then assess core complex formation through western 
blotting.  This way I could determine if CagX, Y and A are truly required for core 
complex formation, or simply for direct interaction with the CagA-CagF complex 
since, I am purifying the complex in a directly tagged manner.   
Overall, this study provides biochemical and biophysical characterization of 
the core complex of the cag T4SS.  I showed that all five predicted proteins of the 
core complex co-sediment through the glycerol gradient, and this complex is 
separate from the CagA-CagF complex.  I also showed that I could purify the same 
core complex using a FLAG tagged copy of CagT, confirming my earlier 
results.  Finally, I showed that CagX, Y and A are required for purification of the 
core complex using HA-CagF, while Cag3, T, and M are dispensable.  All together 
these results provide a solid groundwork for understanding the composition and 
structural organization of the cag T4SS core complex.      
 49  
CHAPTER IV 
NEGATIVE STAIN TRANSMISSION ELECTRON 
MICROSCOPY ANALYSIS OF THE cag T4SS 
CORE COMPLEX 
Introduction 
In the previous chapter I showed that I could isolate five predicted members 
of the core complex and those five proteins formed a complex that would co-
migrated through a density gradient. This represents the first time that the cag core 
complex has been isolated.  
The next logical step is to analyze the structure of this large 
complex.  Negative stain EM provides an attractive option; since the complex is as 
large as it is, I should be able to visualize it with relative ease.  Furthermore, I have 
a panel of mutants which should allow me to isolate complexes that are missing 
certain proteins.  By imaging these mutants and comparing them to WT core 
complex, I can localize these various proteins based on the change in structure.  I 
can also use techniques such as immunogold labeling to localize various 
proteins.   
In the first chapter I showed that I could isolate core complexes from 
bacteria that had been co-cultured with gastric epithelial cells.  There was no 
difference in the protein composition of these core complexes compared to ones 
that were isolated from pure culture.  However, while the protein content remains 
the same, there could be some kind of conformational shift that occurs resulting in 
 50  
CagA translocation into host cells.  EM would be an excellent venue to assess any 
kind of major conformational shift in response to these changes in conditions.   
  
 51  
Materials and Methods 
Negative-stain electron microscopy 
Samples were prepared for EM as previously described (45). In brief, 5-µl 
aliquots of samples were absorbed to a glow-discharged 400-mesh copper grid 
covered with carbon-coated collodion film. Grids were washed in four drops of 
water and then stained with two drops of uranyl formate (0.75%). Samples were 
imaged on a Morgagni electron microscope (FEI, Hillsboro, OR) operated at an 
acceleration voltage of 100 kV and equipped with a 1kx1k charge-coupled-device 
(CCD) camera (ATM). Images were recorded at a magnification of ×28,000. 
Images used to generate class averages were collected using a TF20 electron 
microscope (FEI, Hillsboro, OR) equipped with a field emission gun with an 
acceleration voltage of 200 kV under low-dose conditions at ×62,000 magnification 
and a defocus value of ~1.5 µm on a 4kx4k Gatan Ultrascan CCD camera. 
Class average generation 
Images were converted to mrc (mixed raster content) and binned using a 
value of 2, resulting in images of 3.5 Å/pixel. For alignment and averaging, 445, 
416, and 149 images of wild-type complexes, Δcag3complexes, and ΔcagT 
complexes, respectively, were selected with Boxer and windowed with a 180-pixel 
side length (63 nm). Image analysis was conducted with Spider (46). The images 
were rotationally and translationally aligned and subjected to 10 cycles of 
multireference alignment and K-means classification. For analysis of wild-type 
complexes, particles were classified into 10 class averages and then 5 
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representative classes were chosen as references for multireference alignment. 
For analysis of Δcag3 complexes, particles were classified into 20 class averages 
and then 4 representative projections were chosen as references for another cycle 
of multireference alignment. For analysis of ΔcagT complexes, particles were first 
classified into 10 class averages and then 3 representative projections were 
chosen as references for another cycle of multireference alignment. 
Immunogold labeling of protein complexes 
Immunogold labeling of protein complexes was performed on glow-
discharged carbon-coated grids. Purified core complex preparations were applied 
to grids and blocked with 0.1% cold fish skin gelatin in 50 mM sodium cacodylate 
for 30 minutes at 4°C in a sealed container. Excess blocking buffer was removed 
with filter paper, and then the grid was incubated with primary antibody (rabbit anti-
Cag3 serum (34)) in 50 mM sodium cacodylate, at a dilution of 1:50 for 45 minutes 
at room temperature. Excess primary antibody was removed using filter paper, and 
the grid was rinsed three times for five minutes each in 10 mM HEPES with 300 
mM NaCl at pH 7.0 at room temperature. Excess PBS was removed, and then the 
grid was incubated in secondary anti-rabbit antibody conjugated to 5 nm gold 
particles (EMS) at a dilution of 1:50 in 0.1% cold fish skin gelatin in 50 mM sodium 
cacodylate for 45 minutes at 4°C. The grids were rinsed three times in 10 mM 
HEPES with 300 mM NaCl at pH 7.0 at room temperature, and stained with 0.75% 
uranyl formate prior to transmission EM. 
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Results 
Ultrastructure analysis of the core complex 
To analyze the ultrastructure of the cag T4SS core complex, H. pylori strain 
HA-CagF (containing an intact cag PAI) was grown in liquid culture, complexes 
were isolated using the CagF-based immunopurification procedure, and the 
resulting complexes were visualized using negative-stain single-particle EM. EM 
analysis revealed homogeneous ring-shaped complexes, characterized by well-
defined central and outer rings (Fig. 6a). We also used negative-stain single-
particle EM to analyze fractions of a glycerol gradient to which the immunopurified 
sample had been applied, and detected the ring-shaped complexes in the gradient 
fractions that contained Cag3, CagT, CagM, CagX, and CagY but not in the 
fractions collected from the top of the gradient (see Fig. 7). Since the gradient 
fractions containing these five Cag proteins were free of other non-Cag proteins 
(Fig. 7b; see also Table 3), this result provides evidence that the complexes 
visible by EM were composed of Cag proteins. 
CagA is not actively secreted during H. pylori growth in liquid culture, but 
coculture of H. pylori with gastric epithelial cells is a trigger for translocation of 
CagA into host cells (12, 36). Therefore, although we did not detect substantial 
changes in the protein composition of the immunopurified samples in response to 
epithelial cell contact (see Table 2), we hypothesized that the structural 
organization of the complexes might change when H. pylori contacts gastric 
epithelial cells. To investigate this possibility, we cocultured AGS gastric epithelial 
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cells with HA-CagF-producing H. pylori, purified HA-CagF from lysates of the 
coculture, and then analyzed the immunopurified core complexes by negative-
stain EM. The protein complexes isolated from H. pylori-AGS cocultures were 
similar in appearance to the complexes isolated from H. pylori liquid cultures, but 
the complexes isolated from cocultures were present in relatively low abundance 
and had a less homogeneous appearance (suggestive of degradation) than 
complexes isolated from liquid cultures (Fig. 6b). Similarly, the complexes in 
fractions collected from glycerol gradients had suboptimal morphology and 
exhibited increased clumping compared to complexes in preparations that were 
not passed through a gradient (see Fig. 7). Consequently, all of the subsequent 
experiments focused on complexes isolated from H. pylori grown in liquid culture 
without use of gradient procedures. 
To further characterize the structural features of the complexes, we 
collected a data set containing a larger number of particles, classified them into 10 
class averages using reference-free alignment (Fig. 8a), and then selected five of 
these as references for an additional round of reference-based alignment (see Fig. 
8a and b). This analysis revealed well-defined classes, corresponding to en face 
and side views of the T4SS complex (Fig. 6c). The en face class shows a well-
defined complex, 41 nm in diameter, composed of a central and outer ring 
connected by short linkers. The central ring is 19 nm in diameter. Fourteen linkers 
or “spokes” connect the central and outer ring. The side view reveals a stalk-like 
structure about 40 nm in length, most likely corresponding to the central ring seen 
in the en face views that extends away from the ring-like portions of the complex.   
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Figure 6: Negative-stain EM analysis of the H. pylori cag T4SS core complex. 
(a) Representative negative-stain images of WT cag T4SS complexes purified 
from a strain with an intact cagPAI that was engineered to produce HA-CagF. (b) 
Representative negative-stain images of WT cag T4SS complexes purified from an 
HA-CagF-producing strain (ΔcagF/HA-CagF) cocultured with AGS cells. (c) Class 
averages (Class Avg) showing an en face view and a side view of WT complexes. 
(d) Representative negative-stain images of cag T4SS complexes purified from a 
Δcag3strain engineered to produce HA-CagF. (e) Class averages of the cagT4SS 
complex purified from a Δcag3 strain. (f) Representative negative-stain images of 
cag T4SS complexes purified from a ΔcagTstrain engineered to produce HA-
CagF. (g) Class averages of the cagT4SS complex purified from a ΔcagT strain. 
Numbers of particles used for generating each average are shown in upper left 
corner of panels. All scale bars represent 25 nm. 
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Figure 7: Negative-stain EM analysis of glycerol gradient fractions 
containing the cag T4SS core complex. Preparations resulting from 
immunoaffinity purification of HA-CagF were analyzed by velocity sedimentation in 
glycerol density gradients as shown in Fig. 4, and gradient fractions were analyzed 
by negative-stain EM. (a) Representative negative-stain EM images of fraction 1 
(top of the gradient), which contains CagA and CagF but no core complex 
components. (b) Representative negative-stain EM images of fraction 6 (near 
bottom of the gradient), which contains cag core complex components. Fraction 1 
contained no complexes as visualized by EM (a), while cag T4SS complexes were 
observed in images taken from fraction 6 (b). Scale bar, 25 nm.   
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Figure 8: Negative-stain 2D class averages of WT cag T4SS complexes and 
complexes purified from Δcag3 or ΔcagT mutant strains. (a) Reference-free 
alignment of 445 particles isolated from an HA-CagF-producing strain with an 
intact cag PAI into 10 classes. Five classes (marked with %, @, $, #, and & 
symbols) were chosen as references for an additional round of multireference 
alignment. (b) Result of reference-based alignment. (c) Reference-free alignment 
of 416 particles isolated from a Δcag3/HA-CagF-producing strain into 20 classes. 
Four classes (marked with %, @, $, and # symbols) were chosen as references for 
an additional round of multireference alignment. (d) Result of reference-based 
alignment. (e) Reference-free alignment of 149 particles isolated from a 
ΔcagT/HA-CagF-producing strain into 10 classes. Three classes (marked with %, 
@, and $ symbols) were chosen as references for an additional round of 
multireference alignment. (f) Result of reference-based alignment. Numbers of 
particles used for generating each average are shown in upper left-hand corner of 
the panels. Side length of panels, 63 nm.   
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Ultrastructure analysis of complexes formed by mutant strains 
The immunoprecipitation analyses of mutant strains shown in Fig. 5 
suggested that incomplete complexes could be formed in the absence of Cag3, 
CagT, or CagM (Fig. 5b and d). To investigate these incomplete complexes 
further, we applied the CagF-based immunopurification procedure to these mutant 
strains and then analyzed the resulting complexes by negative-stain EM. We first 
imaged preparations derived from the ΔcagX mutant (containing CagA and CagF 
but not any components of the core complex, based on immunoblotting results) 
(Fig. 5b and d). Consistent with the absence of core complex components 
detectable by immunoblotting, we did not visualize any ring-like structures in these 
preparations. 
We then imaged complexes isolated from the Δcag3 mutant (lacking Cag3 
but containing CagX, CagY, CagT, and CagM, based on immunoblot analysis 
results). The complexes detected in these preparations contained a well-defined 
ring, but there was a marked reduction in peripheral content and no evidence of a 
well-organized outer ring (Fig. 6d). To further characterize the structural features 
of complexes purified from the Δcag3 mutant, we collected a data set of particles 
and generated class averages (Fig. 8c and d). These averages revealed en face 
views of a 19-nm-diameter ring (Fig. 6e). Unlike images and classes of wild-type 
T4SS core complexes, the 2D class averages of complexes isolated from the 
Δcag3 mutant contained no outer ring or connecting spokes (Fig. 6e). The 
absence of peripheral components in complexes from the Δcag3 mutant without 
any obvious perturbation of the 19-nm-diameter ring provides evidence that Cag3 
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is localized to the periphery of the complex. To further test this hypothesis, we 
immunolabeled purified WT core complexes as well as complexes from the Δcag3 
mutant with primary polyclonal antibodies reactive to Cag3, followed by a 
secondary antibody conjugated to 5-nm-diameter gold particles. Imaging of the 
labeled wild-type complexes by negative-stain EM revealed gold particles in the 
periphery of the complexes, but no gold particles were associated with the central 
ring (Fig. 9a). Mutant complexes lacking Cag3 were not labeled with gold particles 
(Fig. 9b), demonstrating the specificity of the immunolabeling. These immunogold 
EM results corroborated the conclusion that Cag3 is a peripheral component of the 
cag T4SS core complex. 
We also imaged complexes isolated from the ΔcagT mutant (lacking both 
Cag3 and CagT). Similarly to complexes isolated from the Δcag3 mutant, the 
complexes isolated from the ΔcagT mutant contained a single well-defined ring but 
no well-organized outer ring (Fig. 6f). The ΔcagT mutant complexes were less 
abundant than the Δcag3 mutant complexes. In order to characterize the structural 
features of complexes purified from the ΔcagT mutant, we collected a data set of 
particles and generated class averages (Fig. 8e and f). The en face views indicate 
that the diameter of the ring in complexes from the ΔcagT mutant is similar to the 
diameters of the rings in complexes from the Δcag3 mutant and WT strains (Fig. 
6g), but the ring in complexes from the ΔcagT mutant appears to have a reduced 
thickness. Unlike images and classes of wild-type T4SS core complexes, the 2D 
class averages of complexes isolated from the ΔcagT mutant contained no outer 
ring or connecting spokes (Fig. 6g). Immunogold labeling of CagT was attempted 
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using complexes purified from WT and ΔcagT strains; however, the results were 
inconclusive due to the nonspecific binding of the anti-CagT polyclonal antibody 
under these conditions. We also analyzed preparations derived from the ΔcagM 
mutants (which lack Cag3, CagT, and CagM) but were unable to visualize any 
ring-shaped complexes in these preparations. The absence of detectable ring-like 
complexes in preparations from the ΔcagM mutant could be due to a reduced 
stability of these complexes, or, alternatively, ring-shaped complexes may fail to 
assemble in the absence of CagM. Collectively, the structural differences between 
mutant and WT complexes, combined with specific antibody labeling, confirm that 
the ring-like structures seen by negative-stain EM correspond to the T4SS core 
complex. 
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Figure 9: Localization of Cag3 by immunogold labeling and negative-stain 
EM. Negative-stain EM images of WT core complexes, isolated from a strain with 
an intact cag PAI (a) or a Δcag3 mutant (b) and subjected to immunogold labeling 
with primary anti-Cag3 antiserum followed by 5-nm-diameter-gold-particle-
conjugated secondary antibodies, are shown. Arrowheads indicate representative 
gold particles. Images are representative of results from three independent 
experiments. Scale bar, 25 nm. 
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Analysis of complexes formed by mutant strains of certain cag genes 
required for T4SS activity 
Every integral member of the core complex is required for H. pylori induced 
IL-8 production in gastric epithelial cells and for the translocation of 
CagA.  However, there are ten additional Cag proteins that are also required for IL-
8 induction, namely Cag4, Cagα, CagW, CagV, CagU, CagH, CagI, CagL, CagE 
and CagC.   These Cag proteins could potentially be playing a role in core 
complex formation.  To address this hypothesis, I analyzed mutant strains where 
cagV, cagH, cagI, cagL, cagE and cagC had been individually deleted and then 
engineered to express HA-CagF, allowing purification of the core complex.  I 
assessed core complex formation through either western blotting or electron 
microscopy.  Through these analyses, I found that six of the proteins I tested were 
required for core complex formation.  (Fig. 10).   
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Figure 10: Immunopurification of HA-CagF from a panel of cag mutant 
strains. (a) HA-CagF was immunoaffinity purified from indicated mutant strains 
which each produced HA-CagF and analyzed by western blotting with indicated 
antibodies.  Strains are designated at the bottom of the panel, and antisera are 
designated at the left side of the panel.  E refers to elution, and FT is flow-through 
from the elution and acts as a positive control. (b) Negative stain EM of HA-CagF 
immunopurifications from indicated mutant strains.  Strains are designated at the 
bottom of the panel. (c) Summary of results from the experiments presented in 
panel a and b, indicating the requirement for core complex formation from mutant 
strains as determined by either western blotting or EM analysis. 
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Figure 11: Schematic model of the H. pylori cag T4SS core complex. (a) 
Prominent features of the complex include an outer ring (light blue) and central 
ring (red) connected by 14 spokes (dark blue). Analysis of complexes from mutant 
strains suggests that Cag3 and CagT are localized to the periphery of the intact 
wild-type complex. (b) Comparison of the diameters and components of T4SS core 
complexes from H. pylori, E. coli, and L. pneumophila. 
  
 65  
Discussion 
EM analysis of the isolated core complexes revealed homogeneous ring-
shaped structures, 41 nm in diameter, characterized by a central ring connected to 
an outer ring by thin spoke-like linkers (Fig. 11a). The presence of 14 visible 
spoke-like linkers in the class averages suggests that the complex may have 14-
fold rotational symmetry, but three-dimensional (3D) structural analysis will be 
required for an accurate assessment of the symmetry. A side view of the complex 
reveals a long stalk-like domain 40 nm in length that likely corresponds to the 
central ring seen in the en face view. Since all of the core complex components 
identified in the current study (CagX, CagY, CagT, CagM, and Cag3) have been 
detected previously on the external surface of H. pylori or as components of the 
outer membrane (35, 40), we propose that the complex is associated primarily with 
the outer membrane. 
Analyses of complexes isolated from a Δcag3 mutant strain, along with 
immunogold labeling experiments, indicate that Cag3 is localized to the periphery 
of the core complex. Specifically, the complexes formed by the Δcag3 mutant 
strain (containing CagX, CagY, CagM, and CagT, based on immunoblot analysis 
results) have an intact 19-nm-diameter ring but exhibit a significantly reduced 
overall diameter compared to wild-type complexes, attributable to loss of the outer 
ring and spoke-like linkers. We speculate that the substantial loss of peripheral 
components in complexes from the Δcag3 mutant reflects not only the absence of 
Cag3 but also an alteration in the structure of residual peripheral components so 
that they are structurally disordered and no longer visible by EM. Complexes 
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isolated from a ΔcagT mutant strain (containing CagX, CagY, and  CagM, based 
on immunoblot analysis results) also contained an intact 19-nm-diameter ring and 
exhibited a loss of visible peripheral components. The complexes from the ΔcagT 
mutant appeared similar to the Δcag3 complexes except that the ring appeared to 
have a reduced thickness. The incomplete complexes derived from Δcag3 or 
ΔcagT mutant strains might correspond to intermediate or premature stages in the 
assembly process that leads to formation of the complete core complex. 
Previous studies have analyzed the 3D structure of the T4SS core complex 
encoded by the E. coli pKM101 conjugative plasmid, which is composed of three 
proteins, VirB7/TraN, VirB9/TraO, and VirB10/TraF (16). The pKM101 T4SS core 
complex is organized into a ring-like structure, 18.5 nm in diameter, with 14-fold 
symmetry (16) and is localized primarily to the outer membrane. Core complexes 
isolated from the A. tumefaciens VirB/D4 T4SS are similar in size (about 20 nm in 
diameter) (47). Therefore, the H. pylori cag T4SS core complex (41 nm in 
diameter) is substantially larger in size than either the pKM101-encoded core 
complex (21) or A. tumefaciens core complex (47) (Fig. 11b). Moreover, the H. 
pylori core complex is composed of five Cag proteins, whereas core complexes 
from the pKM101 and A. tumefaciens T4SSs contain only three (VirB7/TraN, 
VirB9/TraO, and VirB10/TraF) (16, 21) (Fig. 11b). Despite these differences in size 
and overall architecture, it is notable that 14 linkers or spokes connecting the 
central ring to the outer ring could be visualized in the class average of H. pylori 
cag T4SS complexes, which suggests that the cag T4SS core complex may have 
14-fold rotational symmetry similar to that of the pKM101 core complex. It is also 
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notable that the central ring of the H. pylori cag T4SS core complex has a diameter 
(19 nm) similar to those seen with the T4SS core complexes of E. coli and A. 
tumefaciens (16, 21, 47), suggesting that the overall structural organization may 
be conserved.    
Only two components of the H. pylori cag T4SS core complex exhibit 
sequence similarity to components of previously studied T4SS core complexes. 
Specifically, CagX and CagY exhibit sequence relatedness to VirB9 and VirB10 
(Fig. 11b). We propose that CagX and CagY are localized to the central ring of the 
cag T4SS core complex. Consistent with this view, the complexes isolated from 
Δcag3 and ΔcagT mutants contained CagX and CagY and had intact rings (with 
diameters similar to that of the central ring of WT complexes) but lacked the 
structurally organized outer ring and connecting spokes visualized in WT T4SS 
complexes. 
The exact composition of core complexes in effector protein-translocating 
T4SSs has not previously been determined for most bacterial species, though the 
Legionella Dot/Icm core complex is reported to contain at least five proteins (DotC, 
DotD, DotF, DotG, and DotH) (31). Recently published EM images of the 
Legionella Dot/Icm T4SS core complex indicate that it is organized as a circular 
structure 38 nm in diameter (31). Thus, the size of the H. pylori core complex 
analyzed in the current study is more similar to that of the Legionella Dot/Icm core 
complex than to those of Agrobacterium or pKM101 core complexes (Fig. 11b). 
Another notable similarity between the H. pylori cag and Legionella Dot/Icm T4SSs 
is that the core complexes of the two systems have constituents not widely 
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conserved in T4SSs of other bacterial species. Three H. pylori core complex 
constituents (Cag3, CagM, and CagT) seem to be unique species-specific 
adaptations, and three Legionella core complex constituents (DotC, DotF, and 
DotD) are absent fromT4SSs in most other bacterial species. The H. pylori cag 
T4SS translocates CagA across the plasma membrane of gastric epithelial cells, 
whereas the Legionella Dot T4SS translocates several hundred effector proteins 
across endosomal membranes in eukaryotic cells. The existence of specialized 
adaptations in H. pylori and Legionella T4SS core complexes is consistent with the 
considerably different functions of the T4SSs in these two species. 
In future studies, it will be important to investigate the molecular 
mechanisms by which the H. pylori cag T4SS mediates CagA translocation into 
host cells. One possibility is that CagA may pass directly through the central pore 
visible within the core complex. Analysis of the crystal structure of CagA (amino-
terminal residues 1 to 876) indicates that it has dimensions of 8 by 11 by 5.5 nm 
(48), so either a folded CagA protein or an unfolded CagA protein could 
conceivably fit through the ~10-nm pore of the core complex. The mechanisms by 
which CagA enters host cells after translocation across the bacterial envelope 
remain a topic of inquiry. T4SS-associated pili assembled at the bacterium-host 
cell interface presumably contribute to the entry of CagA into host cells (34, 49, 
50), and it has been suggested that binding of CagA to phosphatidylserine or 
integrins on the surface of host cells also may be important for entry into host cells 
(51, 52). 
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There are 18 proteins encoded the cag PAI that are required for T4SS 
activity, including the five proteins that form the core complex. It is possible that 
these other Cag proteins that are required for T4SS activity because they act as 
accessory proteins for the core complex, and might aid its formation or 
function.   However, some are more likely candidates than others.  For example, 
both CagE and Cagα are predicted to be ATPases that provide the energy for 
CagA translocation or pilus formation.  The core complex most likely forms in the 
periplasm or outer membrane which lack ATP and therefore core complex 
assembly probably does not require the use of ATPases.   And, core complex 
does not require CagE for its formation, but the effect that Cagα might have on the 
core complex is still unknown. 
CagC is another Cag protein required for T4SS function, and its own 
function is unknown; it was predicted to be the major pilin subunit, but when it is 
deleted, H. pylori still can form pili (26).  However, when CagC is deleted, I can still 
isolate the core complex, so it is not involved in that function.   
CagH, I, and L are all required for T4SS phenotypes, and interestingly, 
these proteins form a complex.  The deletion of cagH results in a hyper-pilated 
bacteria, whilst the deletion of either cagI or cagL results in a lack of pilus 
production (34).  However, the loss of any of these proteins still results in the 
formation of the core complex, so these proteins are not accessory proteins to the 
core complex.   
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One gene that I predict might be involved in core complex assembly would 
be Cag4, which is predicted to be a peptidoglycan hydrolase.  It is predicted to 
digest the peptidoglycan layer in the periplasm, thus allowing the T4SS machinery 
to span from the outer membrane to the cytoplasm.  I do not think that Cag4 would 
directly regulate the core complex formation per se, but, without the opening in the 
peptidoglycan, I think that the core complex would form in the periplasm, but be 
unable to integrate into the outer membrane.  Under these circumstances the core 
complex would then be swiftly degraded by the proteases in the periplasm. 
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CHAPTER V 
OPTIMIZATION OF cag T4SS CORE COMPLEX 
PURIFICATION FOR 3D RECONSTRUCTION 
Introduction 
In the previous chapter I utilized negative stain electron microscopy to 
better visualize the structural details of the cag T4SS core complex.  Using this 
technique, I discovered that the core complex is a large ring-like structure about 40 
nm in diameter, containing a central ring that is connected to an outer ring by 14 
spokes.  Furthermore, I was to localize Cag3 and CagT to the outer ring, through 
immunogold labeling and mutagenesis studies.   However there are several 
shortcomings of the negative stain data.  First, there is a resolution limit of 20Å. 
And secondly, samples are that are imaged with electron microscopy are done so 
under high vacuum which causes severe flattening and dehydrating effects (45).    
I wanted to improve and refine my initial findings and learn more details 
about the structure of the core complex.  NMR (nuclear magnetic resonance) and 
crystallography are two traditional methods that are used for this 
purpose.   However, NMR is only effective for small proteins less than 50 kDa in 
size, and thus is not at all appropriate for this large complex.  Crystallography can 
resolve the structure of large proteins and even large protein 
complexes.  However, it is very difficult for large protein complexes to crystallize, 
and crystallization requires milligrams of material, which cannot be obtained with 
my current IP methodology.   
 72  
In the past, low resolution structures have been obtained using negative 
stain data with a technique called random conical tilt (RCT).  In this technique, 
images are collected at 0° and 60°, and then particle pairs at picked, so there is 
data about one specific particle at both 0° and 60°.  The untilted data allows us to 
sort the particles into their respective classes, as well as sorting out bad particles 
or mispicked ones, and then we can model the 3D structure based on the tilted 
data .  This technique at its best will produce a structure at about 20-18Å, but will 
produce a 3D model, which is more information than I currently have. However, 
the most optimal approach is cryo-electron microscopy (cryoEM).  In this 
technique, the samples are plunged in vitreous ice, which doesn’t form damaging 
ice crystals, and thus preserves the sample in its biologically-relevant state.  When 
encased in this vitreous ice, the sample will also be protected from the flattening 
effects of the vacuum present in the microscope.  With advances in both camera 
and microscope technology we can now achieve atomic resolution of protein 
complexes using cryoEM in their near biological state.  Furthermore, this technique 
is far more successful than x-ray crystallography in obtaining high-resolution 
structural data of large multiprotein complexes. 
The technique to obtain high-resolution data from cryoEM data is called 
“single particle analysis” (SPA).  In brief, a large dataset of tens of thousands of 
particles (or hundreds of thousands) are collected and all of these particles are 
averaged together to then provide the data for a 3D model.  The assumption is that 
these particles are randomly orientated in the vitreous ice, giving us several 
viewpoints of the same complex and allowing us to accurately model in 3D 
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space.  It is a powerful technique, but it comes with several limitations.  Samples 
cannot be stained to keep resolution under 20Å, so all the contrast of the images 
must come from the size of the particle.  Luckily, the core complex is quite large, 
so it should be relatively easy to visualize.  Furthermore there can be very little 
detergent present in cryo samples.  Unfortunately, since the core complex is a 
membrane associated complex, there is a high level of detergent present in the 
sample, so the concentration of detergent needs to be reduced to allow imaging. 
Also, since only very large datasets can provide high resolution data, the sample 
has to be concentrated; otherwise the man hours needed to gather enough images 
would simply be impractical.  I need to greatly increase the concentration of my 
sample; it was even difficult to get enough images for negative stain 2D 
classification.  And finally, since the assumption is that the particles are randomly 
oriented in the vitreous ice, they cannot be touching, or clustering about one 
another, since this forces the particles into preferential orientations and biases the 
dataset.  In the negative stain EM that I have, I can tell that the core complex tends 
to cluster with itself so this is another hurdle that needs to be addressed.  
In this chapter I will show all my efforts to modify my IP protocol to produce 
a sample amenable to cryoEM as well as my attempts to make a 3D structure of 
the core complex using RCT. 
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Materials and Methods 
Random conical tilt imaging 
Samples for EM were prepared as described above.  Tilt pairs were 
collected at -60° and 0° using a TF20 electron microscope (FEI, Hillsboro, OR) 
equipped with a field emission gun with an acceleration voltage of 200 kV under 
low-dose conditions at ×25,000 magnification and a defocus value of ~1.5 µm on a 
4kx4k Gatan Ultrascan CCD camera.   
Class average generation for RCT 
Images were converted to mrc (mixed raster content) and binned using a 
value of 2, resulting in images of 4.4 Å/pixel. For alignment and averaging, 2,526 
paired particles of wild-type complexes were selected with WEB and windowed 
with a 100-pixel side length (44 nm). Image analysis was conducted with Spider 
(47). The images were rotationally and translationally aligned and subjected to 10 
cycles of multireference alignment and K-means classification. Particles were 
classified into 40 class averages and then 6 representative classes were chosen 
as references for multireference alignment.  
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Results 
Optimization of core complex isolation protocol for cryoEM 
Negative stain EM and class averaging provided me with a solid overall 
morphology of the core complex.  Next, I wanted to be able to obtain high-
resolution data of this complex.  To do this, I turned to cryo-electron microscopy 
(cryoEM).  This technique plunges the sample in liquid ethane, creating vitreous 
ice, protecting the sample from the flattening and dehydration effects present in 
EM.   
However, the conditions amenable for cryoEM are strict.  The sample 
ideally will have no detergents, though low levels are tolerated.  Furthermore, the 
sample has to be concentrated, ideally with several particles per viewfield.  And 
finally, the particles need to be spaced out and not clustered 
together.  Unfortunately my current protocol to isolate the core complex provides a 
sample that has both a high detergent content and dilute concentration, not to 
mention that the core complex has a tendency to cluster.  
I first attempted to find another way to purify the core complex.  IPs usually 
do not provide significant yield, and also my method is an indirect one, since CagF 
isn’t an integral part of the core complex.  In the previous chapter, I mentioned that 
I had been able to purify the core complex using a FLAG tag to CagT.  However, 
that purification was even more dilute that using the HA-CagF (Table 4). I also 
tagged CagX, Cag3, and CagM with HA tags (see table 4) but none of these 
purifications yielded  the core complex.   Then I turned to using a variety of small 
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affinity tags.  The strep-tag is a small eight amino acid tag that can bind to strep-
tactin resin (an engineered form of strepavidin) and then be specifically eluted 
using desthiobiotin.  The core complex from E. coli was purified using a strep tag 
on the C-terminus of VirB10.  However I was unable to purify the core complex 
with strep-tagged copies of CagA, CagF, or CagY (Table 4).  After the failure of 
the strep tags, I turned to another small affinity tag, namely a 13xHis tag.  I tagged 
both CagF and Cag3 with a 13xHis tag, both at their N-and C-terminus.  Cag3 has 
a signal sequence, so the His tag was placed after the signal sequence, therefore 
after modification of the protein by the Sec machinery the His tag is at the N-
terminus.  I was able to recover the core complex from the strain producing the N-
terminally tagged Cag3 construct based on western blot analysis.  However, I was 
not able to visualize any core complex from this strain using EM.  This was likely 
due to the high level of contaminating proteins in the sample.  (Table 4) Thus far, it 
seems that the most consistent way to isolate the core complex has been by using 
the HA-CagF construct.   
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Table 4: Alternative methods of tagging to isolate the core complex 
 
  
 
Proteins purified 
(assessed by 
immunoblot) 
EM results 
ΔCag3/Cag3-HA61H Cag3 N/A 
ΔCag3/Cag3-13xHis22A Cag3, T, M, X, and Y 
Unable to visualize 
core complex 
ΔCag3/Cag3-13xHis None N/A 
ΔCagM/CagM-HA18A CagM N/A 
ΔCagM/ CagM-HA232D none N/A 
ΔCagX/CagX-HA26A none N/A 
ΔCagT/CagT-FLAG55K CagT, X N/A 
ΔCagT/CagT-FLAG106K none N/A 
ΔCagT/CagT-FLAG210Y Cag3, T, M, and X 
Unable to visualize 
any complex 
ΔCagT/CagM-HA18A none N/A 
ΔCagT/CagX-HA26A none N/A 
CagY-strep none N/A 
ΔCagF/Strep-CagF none N/A 
ΔCagF/13xHis-CagF CagY (non-specific) N/A 
ΔCagF/CagF-13xHis CagT (non-specific) N/A 
Strep-CagA none N/A 
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Then I turned to changing the detergent conditions to find a better mix, and 
potentially lower the detergent concentration compared to the RIPA mix I typically 
used, which contains 1% NP-40 and 0.25% DOC.  However, after extensive 
testing (Table 5), the only other detergent that seem to work are 1% or 0.5% NP-
50 paired with 0.5% CHAPS.  But, EM revealed that the core complexes obtained 
using these conditions are even more dilute, and there seemed to be residual 
membrane still bound to the complexes, obscuring much of their morphological 
detail.  Increasing the NaCl concentration from 100mM to 300 mM in RIPA 
marginally improved the EM, so I moved to that concentration.  
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Table 5: Alternative detergent conditions to isolate the core complex 
Lysisa Wash/elution 
Temp/ 
timing 
Proteins 
purified 
(assessed 
by 
immunoblot)b 
EM 
resultsc 
1% NP-40, 0.25%DOC, 
100 mM NaCl, 20 mM 
HEPES. 
Volume: 10 mL 
0.3%DDM, 
100 mM 
NaCl, 20 mM 
HEPES 
All at 4°C CagA, CagF N/A 
20 mM HEPES, 100 mM 
NaCl, 1 mM EDTA (0.5% 
DDM added after 
sonication) 
Volume: 10 mL 
0.3%DDM, 
100 mM 
NaCl, 20 mM 
HEPES 
All at 4°C CagA, CagF N/A 
20 mM HEPES, 100 mM 
NaCl, 1 mM EDTA (0.5% 
DDM added after 
sonication) 
0.3%DDM, 
100 mM 
NaCl, 20 mM 
HEPES 
All at 4°C, lysate 
over beads for an 
hour 
CagA, CagF N/A 
0.05%DDM, 20 mM 
HEPES, 100 mM NaCl, 1 
mM EDTA 
0.3%DDM, 
100 mM 
NaCl, 20 mM 
HEPES 
All at 4°C, lysate 
over beads for an 
hour 
CagA, CagF N/A 
0.5%DDM, 20 mM 
HEPES, 100 mM NaCl, 1 
mM EDTA 
0.01%DDM, 
100 mM 
NaCl, 20 mM 
HEPES 
All at 4°C, lysate 
over beads for an 
hour 
CagA, CagF N/A 
2% OG, 20 mM HEPES, 
100 mM NaCl, 1 mM 
EDTA 
0.7%OG, 100 
mM NaCl, 20 
mM HEPES 
All at 4°C, lysate 
over beads for an 
hour 
CagA, CagF N/A 
2% OG, 20 mM HEPES, 
100 mM NaCl, 1 mM 
EDTA 
0.7%OG, 100 
mM NaCl, 20 
mM HEPES 
All at 4°C CagA, CagF N/A 
2% OG, 20 mM HEPES, 
100 mM NaCl, 1 mM 
EDTA 
0.7%OG, 100 
mM NaCl, 20 
mM HEPES 
RT CagA, CagF N/A 
1%DM, 20 mM HEPES, 
100 mM NaCl, 1 mM 
EDTA 
0.1%DM, 100 
mM NaCl, 20 
mM HEPES 
RT CagA, CagF N/A 
2% OG, 0.25% DOC, 20 
mM HEPES, 100 mM 
NaCl, 1 mM EDTA 
0.7%OG, 100 
mM NaCl, 20 
mM HEPES 
RT CagA, CagF N/A 
1%DM, 0.25% DOC, 20 
mM HEPES, 100 mM 
0.1%DM, 100 
mM NaCl, 20 
RT CagA, CagF N/A 
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NaCl, 1 mM EDTA mM HEPES 
1% NP-40, 0.25%DOC, 
100 mM NaCl, 1 mM 
EDTA, 20 mM HEPES 
 
0.5%LDAO, 
100 mM 
NaCl, 20 mM 
HEPES 
RT CagA, CagF N/A 
2% LDAO, 100 mM NaCl, 
1 mM EDTA, 20 mM 
HEPES 
 
0.5%LDAO, 
100 mM 
NaCl, 20 mM 
HEPES 
RT CagA, CagF N/A 
1% NP-40, 0.25%DOC, 
100 mM NaCl, 20 mM 
HEPES 
 
0.3% DDM, 
100 mM 
NaCl, 20 mM 
HEPES. 
 
RT CagA, CagF N/A 
1% NP-40, 0.5%CHAPS, 
100 mM NaCl, 20 mM 
HEPES 
 
Unchanged 
from lysis 
conditions 
 
RT Cag3, T, M, 
X, Y, A, F 
unknown 
0.5% NP-40, 
0.5%CHAPS, 100 mM 
NaCl, 20 mM HEPES. 
 
Unchanged 
from lysis 
conditions 
 
RT Cag3, T, M, 
X, Y, A, F 
Very poor, 
but can 
see core 
complex 
1% NP-40, 0.25%DOC, 
300 mM NaCl, 20 mM 
HEPES. 
 
Unchanged 
from lysis 
conditions 
 
RT N/A Clear core 
complex 
but dilute 
1% NP-40, 0.25%DOC, 
300 mM NaCl, 20 mM 
HEPES, pH 9.0 
 
Unchanged 
from lysis 
conditions 
 
RT N/A Clear core 
complex 
but dilute 
1% NP-40, 0.25%DOC, 
300 mM NaCl, 20 mM 
HEPES, pH 11.0 
 
Unchanged 
from lysis 
conditions 
 
RT N/A Clear core 
complex 
but dilute 
1% NP-40, 0.25%DOC, 
500 mM NaCl, 20 mM 
HEPES 
 
Unchanged 
from lysis 
conditions 
 
RT N/A Clear core 
complex 
but dilute 
1% NP-40, 0.25%DOC, 
100 mM KCl NaCl, 20 mM 
HEPES 
 
Unchanged 
from lysis 
conditions 
 
RT N/A Clear core 
complex 
but dilute 
1% NP-40, 0.25%DOC, 
300 mM KCl NaCl, 20 mM 
HEPES 
 
Unchanged 
from lysis 
conditions 
 
RT N/A Clear core 
complex 
but dilute 
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aAll lysis was performed by sonication on ice 
bN/A indicates that immunoblotting was not performed on that condition 
cN/A indicates that EM was not performed on that condition 
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Then, I explored several options to concentrate or increase the yield of the 
core complex.  Unfortunately, it seemed that most of the traditional methods of 
concentration were not amenable to this sample (Table 6).   Every attempt to use 
a concentrator column resulted in aggregation of the core complex or the complex 
binding to the concentrator itself.  Fixation did not solve this problem, nor pre-
clearing the concentrator with BSA.   
I also attempted to use an ammonium sulfate precipitation and speed-vac to 
concentrate the sample, but neither of these techniques were successful (Table 
6).  I then tried longer incubations of the sample on EM grids.  I saw an increase in 
number of complexes after an incubation of two hours, but they were highly 
clustered.  An overnight incubation seemed to cause the core complex to fall apart 
(Table 6). 
There is a relatively new technique that has been used in cryoEM which 
utilizes “amphipols” to reduce detergent concentrations (53).  These are 
amphipathic polymers, which exchange with the detergents surrounding the 
protein, keeping them soluble (54).  Then the free detergent can be bound and 
removed using polystyrene bio-beads.  I was hoping that removing the detergents, 
but still having the amphiphols bound around the core complex would stabilize the 
core complex and reduce clustering.  However,  the exchange with biobeads must 
be done overnight, and I could not visualize the core complex after such a long 
incubation (Table 6), an observation which falls in line with the one I made when I 
incubated the sample overnight on EM grids. 
 83  
Then I used increasing amounts of HA-antibody, hoping to saturate the 
binding of the core complex.  I had been using 5 ug with 50 ul of dynabeads, and 
then I tested up to 30 ug of antibody per 50 ul of dynabeads.  To test the yield of 
the IP, I immunblotted for amounts of CagF which is the being pulled down.  I saw 
a slight increase of CagF at 10 ug of antibody, but I did not see any more increase 
in CagF for any of the higher concentrations of antibody. (Table 6).  Finally, I then 
tried to scale up the IP.  Normally, I use 25 mL of liquid bacterial culture with 50 ul 
of dynabeads, 10 ug of HA-antibody, and eluted in 200 ul.  To scale up, I used 125 
mL of liquid bacterial culture with 250 ul of dynabeads, 50 ug of HA-antibody, and 
eluted in 200 ul, which would be expected to increase the yield and concentration 
five-fold.  This resulted in increased concentration of core complex (assessed by 
EM), though the particles were highly clustered (Table 6).   
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Table 6: Techniques to attempt to concentrate HA-CagF IP elution 
Processa Conditions EM results 
Concentrator column 
Pre-clear with 5% BSA, 
1 mDa nitrocellulose 
column, 4X concentrated 
Aggregated 
Pre-clear with 5% BSA, 
1 mDa PES column 2X 
concentrated 
Unchanged from 
unconcentrated 
Pre-clear with 5% BSA, 
1 mDa PES column 4X 
concentrated 
Aggregated 
Pre-clear with 5% BSA, 
1 mDa PES column 8X 
concentrated 
Aggregated 
Fixation 
0.1% Glutaraldehyde, 5 
minutes 
Looks good 
0.1% Glutaraldehyde, 10 
minutes 
Aggregated 
0.1% Glutaraldehyde, 20 
minutes 
Aggregated 
0.1% Glutaraldehyde, 30 
minutes 
Aggregated 
0.1% Glutaraldehyde, 40 
minutes 
Aggregated 
0.1% Glutaraldehyde, 5 
minutes, concentrate 
with 1 mDa PES column 
Aggregated 
1% PFA, 5 minutes Aggregated 
1% PFA, 10 minutes Aggregated 
1% PFA, 15 minutes Aggregated 
1% PFA, 20 minutes Aggregated 
1% PFA, 15 minutes, 
concentrate with 1 mDa 
PES column 
Aggregated 
Ammonium sulfate precipitation 
50% solution, spin out 
protein, re-suspend in 20 
ul buffer 
Unable to see 
complex 
Speed-vac 
At 4C down to 50 ul Complex made 
more dilute 
Reduction of detergents using 
amphipols 
Add amphipols to IP 
elution, remove 
detergent with biobeads 
(O/N) 
Unable to see 
complex 
EM 
Incubate EM grids in IP 
elution for 2 hours 
Concentrated, but 
clustering 
Incubate EM grids in IP Unable to see 
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elution for O/N complex 
Modifying the IP protocol 
10 ug of HA-antibody/50 
uL dynabeads 
Slightly more core 
complex than 
normal 
15 ug of HA-antibody/50 
uL dynabeads 
Same as 10 ug HA 
antibody 
20 ug of HA-antibody/50 
uL dynabeads 
Same as 10 ug HA 
antibody 
25 ug of HA-antibody/50 
uL dynabeads 
Same as 10 ug HA 
antibody 
30 ug of HA-antibody/50 
uL dynabeads 
Same as 10 ug HA 
antibody 
Use 125 mL starting 
culture, elute in 200 uL 
for an hour 
Concentrated, but 
clustering 
aAll samples were prepared using the RIPA buffer referenced in the first chapter 
unless otherwise stated.  
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Table 7: Techniques to attempt to reduce clustering of core complex 
 
aAddition to buffer EM results  
50 mM Mg2SO4 +1% NP-40, 
0.25%DOC, 300 mM NaCl, 20 mM 
HEPES 
Clustered 
100 mM Mg2SO4 +1% NP-40, 
0.25%DOC, 300 mM NaCl, 20 mM 
HEPES 
Clustered 
200 mM Mg2SO4 +1% NP-40, 
0.25%DOC, 300 mM NaCl, 20 mM 
HEPES 
Less complex 
50 mM NH4SO4 +1% NP-40, 
0.25%DOC, 300 mM NaCl, 20 mM 
HEPES 
Less complex 
100 mM NH4SO4 +1% NP-40, 
0.25%DOC, 300 mM NaCl, 20 mM 
HEPES 
Less complex 
200 mM NH4SO4 +1% NP-40, 
0.25%DOC, 300 mM NaCl, 20 mM 
HEPES 
Less complex 
10 mM MgCl2 +1% NP-40, 0.25%DOC, 
300 mM NaCl, 20 mM HEPES 
Clustered  
20 mM MgCl2 +1% NP-40, 0.25%DOC, 
300 mM NaCl, 20 mM HEPES 
Clustered  
50 mM MgCl2 +1% NP-40, 0.25%DOC, 
300 mM NaCl, 20 mM HEPES 
Clustered 
2 mM BME +1% NP-40, 0.25%DOC, 
300 mM NaCl, 20 mM HEPES 
More aggregation 
5 mM BME +1% NP-40, 0.25%DOC, 
300 mM NaCl, 20 mM HEPES 
More aggregation 
10 mM BME +1% NP-40, 0.25%DOC, 
300 mM NaCl, 20 mM HEPES 
More aggregation 
125 mM Arginine +1% NP-40, 
0.025%DOC, 300 mM NaCl, 200 mM 
HEPES 
Clustered  
250 mM Arginine +1% NP-40, 
0.025%DOC, 300 mM NaCl, 200 mM 
HEPES 
Clustered 
500 mM Arginine +1% NP-40, 
0.025%DOC, 300 mM NaCl, 200 mM 
HEPES 
Less complex 
125 mM Glycine +1% NP-40, 
0.025%DOC, 300 mM NaCl, 200 mM 
HEPES 
Decreased clustering 
250 mM Glycine +1% NP-40, Clustered 
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0.025%DOC, 300 mM NaCl, 200 mM 
HEPES 
500 mM Glycine +1% NP-40, 
0.025%DOC, 300 mM NaCl, 200 mM 
HEPES 
Less complex 
125 mM Arginine+125 mM Glycine 
+1% NP-40, 0.025%DOC, 300 mM 
NaCl, 200 mM HEPES 
Less complex 
125 mM Glycine +0.5% NP-40, 
0.025%DOC, 300 mM NaCl, 200 mM 
HEPES 
Increased clustering 
125 mM Glycine +0.5% NP-40, 300 
mM NaCl, 200 mM HEPES 
Increased clustering 
125 mM Glycine +0.1% NP-40, 
0.025%DOC, 300 mM NaCl, 200 mM 
HEPES 
Increased clustering 
125 mM Glycine +0.1% NP-40, 300 
mM NaCl, 200 mM HEPES 
Increased clustering 
aThe base buffer is 1%NP-40, 0.25% DOC, 300 mM NaCl, and 20 mM HEPES at 
pH 7.0 unless otherwise stated. 
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I now had found a way to obtain a higher concentration of the particles, but 
now I had to find a way to reduce the clustering.  There are several classes of 
additives that can be used to reduce protein aggregation, namely kosmotropes, 
chaotropes, reducing agents and amino acids (55).  I tested a wide variety of these 
additives (Table 7),  and found that the addition of 125 mM glycine, while not 
completely eliminating the clustering substantially improved it.  I then plunged and 
attempted to image these samples using cryoEM (with the help of my collaborator, 
Tasia Pyburn), but the detergent levels were too high and we could not image the 
complex.  I then tried to reduce the amounts of detergent in this sample (Table 7), 
but all reductions in detergent content simply increased the clustering.   
3D reconstruction using random conical tilt   
Since there were so many hurdles with the cryoEM I decided to attempt 
Random Conical Tilt (RCT).  This technique would allow me to obtain a 3D model 
of the core complex, though it would not be high resolution since it will still be 
utilizing negative stain EM. I would image particles at both 0 and 60 and then pick 
particle “pairs”. The untitled data allows us to sort the particle sin to their 
respective classes, as well as sorting bad particles or mispicked ones, and then 
we can model the 3D structure based on the tilted data.  
I used the concentrated sample which contains 125 mM glycine to image for 
the RCT.  I took 218 paired images (436 total images).   I imaged at 25,000x, a 
lower magnification than the one used for the initial generation of class averages, 
in order to have more particles per field of view.  Using the program EMAN2, I 
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picked about 1,000 paired particles, and then attempted a reference free-
alignment to classify them into averages.  However, the averages formed were of 
poor quality, and only consisted of en face views of the core complex, even though 
during the process of picking I saw many side views (data not shown).  I repicked 
this data set using the program WEB,  and this program produced far better 
averages (data not shown) including side views.  This meant that the issue was 
not with the quality of the data, but actually with the program.   
I then went on and gathered 282 more paired images for a total of 500 
paired images including the initial set.  I used the program WEB to pick 2,526 
particles, which were then classified into six reference-based classes, and these 
looked very similar to the averages I previously generated (Fig. 12).  Four of the 
six classes were of the core complex, so these classes were merged together, 
giving us 1,650 particles that I then attempted to reconstruct into a 3D 
projection.  However, this did not produce a proper structure, only a strange disc, 
with unconnected densities (data not shown).  
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Figure 12: Negative-stain 2D class averages of WT cag T4SS from RCT (a) 
Reference-free alignment of 2,526 particles isolated from an HA-CagF-producing 
strain with an intact cag PAI into 40 classes. Six classes (marked with *, &, ^, %, 
and $ symbols) were chosen as references for an additional round of 
multireference alignment. (b) Result of reference-based alignment. Numbers of 
particles used for generating each average are shown in upper left-hand corner of 
the panels. Side length of panels, 44 nm.  
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Discussion 
In this chapter, I attempted to optimize my preparation of the core complex 
to facilitate cryoEM analysis.   There are several issues with my current 
preparation that makes it inappropriate for cryoEM.  First, the sample is far too 
dilute to be efficiently imaged with cryoEM.  Second, the detergent concentrations 
are incompatible with cryoEM.  And finally, the core complex tends to cluster, 
meaning that it takes on preferential orientations, which is not ideal for a cryoEM 
dataset.  However, despite all these issues, there are a lot of advantages of using 
cryoEM to resolve the structure of the core complex.  First, the core complex is 
very large, this means that once it is in the vitreous ice, it should be very easy to 
see, which is often an issue in cryoEM samples.  And, second, it appears that the 
core complex has a high level of symmetry, potentially 14-fold.  This is a huge 
advantage when it comes to single particle analysis.   For example, if I had picked 
1,000 particles of the core complex, assuming that it has a 14-fold symmetry, I 
have the equivalent of 14,000 particles worth of data.  So, despite the hurdles 
presented with this sample, cryoEM seems to be one of the best options open to 
me to study the structure of the core complex.  
At first, I looked for ways to increase the yield of the purification.  The way 
that I have been able to purify the core complex is by immunopurifying CagF, 
which purifies the CagA-CagF complex, and it appears that this complex in turn 
interacts with the core complex.  However the interaction with CagF-CagA 
complex and the core complex is not a very strong one; the two complexes 
dissociate from one another when applied to a glycerol gradient (see chapter 
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3).  So, I thought that if I could find a way to purify the core complex by tagging 
one of the proteins that compose the core complex, perhaps this could increase 
the yield, since I would be relying on a more direct interaction.   While I was able to 
purify the core complex with a specific FLAG tag on CagT, the yield was very poor. 
I also used HA tags on Cag3, CagX, and CagM, but I was unable to purify the core 
complex with these constructs.   I believe that the presence of the antibody is 
sterically hindering the formation of the core complex; I am able to purify the 
protein that is tagged, just not any of its binding partners.  Since I was able to use 
the CagT-FLAG27K construct to purify the core complex, this implies that perhaps 
there are flexible loops or regions that are surface exposed that do not interfere 
with core complex assembly.  Indeed, it makes sense that the CagT-FLAG27K 
construct could purify the core complex, since it was originally designed so that the 
FLAG epitope was inserted into predicted surface exposed, hydrophilic regions of 
CagT.  However, I tested the four other constructs of FLAG-tagged CagT that were 
also predicted to be surface exposed, and none of them worked, so this method to 
place tags is not 100% reliable.   
Since I was having so many issues with directly tagging the core complex 
members, I returned to the interaction that I knew worked, the purification of 
CagF.  Using an affinity tag should allow me to purify a larger amount of 
sample.  However introduction of either His-tags or Strep-tags on CagF did not 
yield any core complex, even if the tags were placed in the exact same position as 
the HA-tag.  I also strep-tagged CagA and CagY, as well as placing His-tags on 
Cag3, but none of these strategies worked.   
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The IP of HA-CagF to date is the most reliable way to purify the core 
complex.  Fortunately, cryoEM does not need a large volume of sample, just a 
concentrated one.  Since the IP elution yields 200uL of purified sample, I could 
concentrate the sample with a concentrator column with a molecular weight cut-off, 
greatly reducing the volume, but still having plenty for EM.  However, the core 
complex seemed to bind to the membranes of concentrator columns, and I could 
not fix the issue with either pre-clearing it with BSA or fixing the core complex 
beforehand.  Other attempts of concentration by reducing the volume, namely by 
ammonium sulfate precipitation and speed-vac, were also unsuccessful.   
So then I turned to modifying the IP protocol itself and found that scaling up 
the IP actually increased the yield, though concentrating the core complex 
increased its tendency to cluster.  It seems as though this is an inherent trait of the 
complex-perhaps hydrophobic regions of the proteins are associating with one 
another.  Most of the proteins do have large hydrophobic stretches since they are 
all membrane associated. The addition of glycine somewhat alleviated the 
clustering problem, but it did not entirely eliminate the problem.   
And, finally, it appears that only a very specific detergent mix will allow an 
HA IP of HA-CagF purify the core complex.  I have tried various different 
combinations of more EM friendly detergents such as DDM, DM, OG and 
LDAO.  In these purifications I could still isolate CagF and CagA, meaning the IP 
was indeed working, but I could no longer isolate the core complex.  This implies 
that there is a very specific and potentially weak interaction of the CagA-CagF 
complex with the core complex that can only be preserved with a certain detergent 
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mix.  The only detergents that could preserve this interaction were either NP-40 
and DOC, or NP-40 and CHAPS.  CHAPS and DOC have similar properties, 
though DOC is an ionic detergent and CHAPS is zwitterionic and considered a 
slightly milder than DOC.  However, these detergents are not compatible with 
cryoEM. And while the amount of NP-40 and DOC can be lowered and still recover 
core complex, the complex clusters even more, and the reduction in detergent is 
still not enough to be used in cryoEM.  
There are other techniques that utilize EM to provide structural data.  One 
of these is RCT, which uses negative stain data.  While it cannot reach the atomic 
resolution of cryoEM, it can provide a 3D model of around 20-18Å in resolution, 
which would provide me with more information that I currently have.  Like cryoEM, 
it relies on single particle analysis and requires a relatively large dataset of 
particles, though not nearly as many for cryoEM.  I found a way to increase my 
yield and decrease the clustering of core complex, so this provided an excellent 
sample for RCT.  While I got class averages that matched previous class 
averages, I was unable to obtain a 3D structure. All the back projections I 
attempted yielded mostly noise and no meaningful data. On possible problem is 
that I analyzed about 1,200 particles when attempting to build a 3D model which is 
on the low end of the spectrum even for RCT. 
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CHAPTER VI 
CONCLUSIONS 
Summary 
Helicobacter pylori is a ubiquitous gastric pathogen that infects over half of 
the world’s population (1, 56).  This bacterium is a common causative agent of 
gastric cancer, which is the second leading cause of cancer deaths in the world. 
Due to this connection, H. pylori has been designated a Class I carcinogen by the 
WHO.   
There is a high level genetic diversity among H. pylori strains, and strains 
producing certain virulence factors are associated with adverse clinical 
outcomes.  One of these virulence factors is the cag PAI, a 40 kb region on the 
bacterial chromosome (5).  The cag PAI encodes the bacterial effector protein, 
CagA as well as a T4SS.  CagA is a bona fide oncoprotein, and contributes to the 
gastric cancer associated with long-term H. pylori infection (33, 57).  
Unsurprisingly, CagA and the cag T4SS have been the focus of many 
studies over the years.  But there have been many hurdles to isolating 
subassemblies of the cag T4SS.  This study is the first to isolate a large 
subassembly of the cag T4SS and study it in isolation.   
Directly tagging proteins that are integral members of the cag T4SS has not 
allowed isolation of protein complexes in the past, so I turned to a more indirect 
approach.  I put a tag on CagF, which is a chaperone of the effector protein 
CagA.  Previous studies have shown that CagA and CagF are binding partners, 
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but have not shown any other interactions involving these proteins (27, 
28).  However, in my hands, I was able to not only purify CagA and CagF using an 
HA-tagged version of CagF, but also five other Cag proteins, namely Cag3, T, M, 
X and Y.  These five proteins correspond to the core complex of the cag 
T4SS.  These results are first time that CagA has been shown to interact with a 
major subassembly of the cag T4SS.  Furthermore, the set of proteins interacting 
with CagA and CagF does not change if the IP is performed from bacteria co-
cultured with gastric epithelial cells.   
To determine if these purified proteins formed a complex, I performed 
differential density centrifugation and I found that I was purifying two separate 
complexes: CagA and CagF co-purified with one another, and that Cag3, T, M, X 
and Y co-purified with one another.  Those five proteins, Cag3, T, M, X and Y are 
all predicted to be the core complex of the T4SS, and thus by showing that they 
co-migrated through a gradient, I have an important piece of evidence that I am 
indeed purifying the core complex of the cag T4SS.  It is worth noting that while I 
can purify the core complex using the CagA-CagF complex as bait; it appears that 
the interaction with the core complex is a transient one.   
I then went on to study the protein-protein interactions that make up the 
core complex.  I deleted the gene of each protein that was in the core complex (as 
well as CagA), and then re-introduced an HA-tagged copy of CagF into these 
mutant strains so I could isolate these mutant core complexes and determine their 
protein composition. Through these studies I found that CagA, CagX and CagY are 
all required for the purification of the core complex.  Every member of the core 
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complex is required for T4SS activity, so it is doubtful that the core complex is not 
being formed in the CagA mutant ; rather, I hypothesize that it is directly interacting 
with the core complex.  Therefore, in the absence of CagA, CagF does not interact 
with the core complex, and I can no longer purify it.  CagX or CagY could be 
required for either the formation or the stability of the core complex, though at this 
juncture we cannot rule out the possibility that they are also required for the direct 
interaction with the CagF-CagA complex.  
The three other proteins that form the core complex, Cag3, CagT, and 
CagM are not required for the purification of the core complex, and I am able to 
purify mutant complexes lacking these compoents.  The Cag3 mutant is only 
missing Cag3, while the CagT mutant is missing Cag3 and CagT, and finally the 
CagM mutant is missing Cag3, T and M.  It appears then that these three proteins 
are directly interacting with one another.   
Every member of the core complex is required for the activity of the T4SS 
as well as active CagA translocation.  However, there are thirteen other Cag 
proteins beyond these five that are also required for T4SS activity.  It is possible 
then, that some of these Cag proteins could also be aiding in the formation of the 
core complex, and thus their loss would cause the loss of T4SS activity and CagA 
translocation.  To test this, I used the same strategy as I did with the integral 
members of the core complex; I deleted the genes encoding Cag proteins required 
for T4SS function, and then engineered these mutant strains to express an HA-
tagged form of CagF to purify the core complex.  Thus far, of the thirteen proteins 
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required, I have been able to test six mutants,  namely Cag H, I, L, E, V and 
C.  None of these proteins are required for core complex formation.  
After these biochemical and biophysical characterizations, I turned to 
negative stain EM to begin to understand the structure of this complex.  En face 
views revealed that the WT core complex had a large, ring-like structure, 
containing an outer ring and a central ring connected by 14 spokes.  The entire 
diameter is 41 nm, while the central ring is 19 nm.  Side views also revealed a 
large stalk protruding from the central ring that is 41 nm in diameter. I was also 
able to visualize these complexes from the fractions in the glycerol gradients 
where the core complex was present, providing further evidence that I am indeed 
visualizing the core complex and not some contaminating complex.  WT core 
complexed isolated from co-culture of H. pylori and gastric epithelial cells have the 
exact same morphology as ones isolated from pure culture, so there is no 
evidence of a conformational shift caused by active CagA translocation.  
I was able to image two mutant core complexes as well, the Cag3 mutant 
(missing Cag3) and the CagT mutant (missing Cag3 and CagT).  These two 
complexes had a remarkably similar morphology: the outer ring was lost, with only 
the central ring remaining. These data imply that Cag3 and CagT are on the outer 
ring of the core complex, a claim further supported by immunogold labeling which 
localizes Cag3 to periphery.  Cag3 and CagT probably do not make up the entire 
outer ring.  Both the Cag3 and the CagT mutants have the exact same morphology 
where the entire outer ring is missing, and the central ring remains completely 
intact, even though the CagT mutant is missing both CagT and Cag3. What could 
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be happening is that the loss of the Cag3 causes a loss in the structural integrity of 
the outer ring, so I can no longer visualize it with EM.  That same loss persists in a 
CagT (which lacks both Cag3 and CagT)  mutant, but since I was already 
visualizing a loss of structural integrity, there doesn’t seem to be an additional with 
the loss of CagT, which tells me that CagT is likewise on the periphery and not in 
the central ring.  
Finally, I wanted to be able to obtain a high-resolution structure of the core 
complex using single particle cryoEM.  Over the past few years, I have attempted 
many different strategies to make this purification amenable for cryo conditions: 
changing which protein is tagged, adjusting the mixture of detergents, and 
attempting various concentrating strategies.  None of these strategies to date have 
been successful.  I also tried to obtain a low-resolution 3D structure of the core 
complex using RCT, but the data set I picked did not yield a 3D structure.  
Despite these setbacks, I was still able to further our knowledge about the 
cag T4SS, and more broadly as T4SS as a whole.   Prior to my studies of the cag 
T4SS all the detailed structural work of T4SS core complexes had been utilizing E 
coli conjugation systems.  This literature showed the core complex to be a small 
ring-like structure about 19 nm in diameter, composed of three proteins (16, 
21).  In contrast, the cag core complex is much larger in size, at 41 nm, and 
composed of five proteins instead of three.  Interestingly though, the central ring of 
the cag core complex is the same size as the E. coli core complex and composed 
of the only proteins with sequence similarity to other systems beyond H. pylori.   
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The body of literature on effector protein translocating T4SSs is quite 
small.  However, a few years ago, EM was used to define the structure of 
Legionella’s Dot/Icm core complex (31).  This core complex had far more 
similarities with the cag core complex than the E. coli core complex. The Dot/Icm 
core complex is also composed of five proteins, and is likewise quite large, about 
38 nm in diameter.  It has a similar overall structure though, namely a large ring 
with a central pore, though it does not appear to have spokes connecting the pore 
to the outer ring (31).  Another study used cryoEM tomography to visualize the 
Dot/Icm core complex in situ, which further emphasized the similarities between 
the Dot/Icm core complex and the cag core complex.  The cryoEM tomography 
revealed that the Dot/Icm core complex was a large complex with a stalk-like 
domain which points into the periplasm and inner membrane (58). Strikingly, an 
overlay of the cag core complex perfectly matches the Dot/Icm core complex in 
both size and overall morphology.  
I believe that this morphology, now seen in both H. pylori and L. 
pneumophila could be a paradigm of effector protein translocating T4SSs. This 
illustrates the vast difference between conjugative T4SSs and effector 
translocating T4SSs, unsurprisingly since their functions are quite diverse.  The 
diversity of T4SS requires continued research, since a single model is not 
adequate to describe the intricacies of this system.   
Future Directions  
My work detailed here provides important new insights into the structural 
organization of the cag T4SS core complex, but there is still much that needs to be 
 101  
elucidated.  Foremost, obtaining a high-resolution structure of the core complex is 
an important goal.  I have attempted to modify my purification methods and 
conditions in order to make the preparation compatible with cryoEM, but thus far 
these efforts have not been successful.  There are still more avenues to attempt, 
including modifying the protocol with amphipols, or perhaps even trying to express 
parts or the entirety of the core complex recombinantly.  Furthermore, there are 
other small tags that I have not yet taken advantage of yet.  For example, the avi-
tag is a 15-amino acid tag that is specifically biotinylated in the presence of biotin, 
biotin ligase and ATP.  I could then use streptavidin to pull down the biotinylated 
protein, and perhaps purify the core complex, if I tag the appropriate protein.  I 
would want to tag CagF with this since this was the protein I tagged to initially 
purify the core complex, as well as Cag3, since I was able to nonspecifically purify 
the core complex using a His-tag on Cag3.  Presumably, the high specificity of the 
biotin-streptavidin interaction will yield a cleaner more highly purified preparation 
than that which was obtained using a 13xHis tag.  
Besides the high resolution structure, there are several other avenues of 
research that are high priority for further study.  In all my studies I have only ever 
been able to purify the core complex and none of the other complexes of the cag 
T4SS.  The core complex should have proximity to the inner membrane core, 
ATPases, and pilus, according to models in E. coli.  This could represent yet 
another divergence between these two systems, but this cannot be proven with a 
lack of data.  In order to delve into this question I would like to take advantage of a 
relatively new technology: BioID.  This technology takes advantage of a point 
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mutant of biotin ligase (BirA*); instead of biotinylating at specific residues, this 
enzyme will promiscuously  biotinylate all proteins within a ~10nm proximity 
(59).  If I engineered this protein into members of the T4SS I could then identify the 
proteins biotinylated and I could start to build a map of the proteins within the 
T4SS.  One drawbacks of this technique, is the large size of BirA* (372 amino 
acids) which might disrupt the structure of the core complex.  CagF and CagA are 
potentially good candidates for fusion, since they lightly interact with the core 
complex, but are not integral members.  By identifying the proteins within close 
proximity to CagA or CagF, I could potentially learn if CagA interacts with CagY or 
CagX.  Furthermore, I could perform the same experiment when the bacteria is 
actively translocating CagA and in contact with gastric epithelial cells. This could 
potentially reveal new interactions between CagA and CagF and these proteins 
would presumably be important for CagA translocation, and also could indicate a 
change or shift in the T4SS machinery to allow for translocation.  
One member of the core complex that I could potentially label with this form 
of biotin ligase would be CagY.  It is a very large protein, and I hypothesize that the 
CagY N-terminus does not interact with the rest of the core complex members, 
merely interfaces with CagA.  I hope then, that by introducing in BirA* to this region 
I could assess the proteins closest to CagY, and it would be interesting to see if 
that would be the ATPases, or the inner membrane core.  This could also be used 
on a variety of under studied Cag protein to identify their interactions with other 
members of the cag PAI and elucidate their role in the T4SS machinery.  
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Besides investigating the intimate interactions between the various 
components of the Cag machinery, there is a lot of value in figuring out the 
proteins required for core complex formation.  Two proteins that might be required 
for the formation of the core complex are CagX and CagY.  If either one of those 
genes are deleted, then the core complex can no longer be isolated using HA-
CagF.  However this could mean that either CagX and CagY are required for the 
interaction of CagF with the core complex, or that they are required for the 
formation of the core complex.  To answer this question, I need an alternative way 
to purify the core complex, and luckily I can do this with the FLAG-tagged version 
of CagT.  I could engineer both of these mutant strains to express the FLAG-
tagged CagT and then assess isolation of the core complex by western blotting.  I 
hypothesize that in the absence of CagY I will still be able to isolate the core 
complex.  I think in this cag system it acts more as an adaptor protein to link CagA 
and the cag T4SS machinery rather than an integral member of the 
machinery.  While CagY is required for both CagA translocation and IL-8 induction, 
in its absence pili are still formed.  Therefore I think it is far more likely that CagX is 
required for formation of the core complex.  This same strategy could be applied to 
assess if CagA is required for core complex formation, though I consider this to be 
unlikely since IL-8 induction is still preserved in the absence of CagA.  
Another interesting question is to determine where and how CagA is 
interacting with the core complex.  Hopefully the bioID technique could shed some 
light on the matter.  I have not yet assessed if CagA and CagF are purified when 
the core complex is purified using the CagT-FLAG construct, but if they can be, 
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this could open up some avenues of research.  We know that CagF is required for 
CagA translocation, but we do not know through which mechanism. As a matter of 
fact, we know very little of the mechanism of CagA translocation at all.  Work by 
Bonsor et al showed that CagF bound to CagA in multiple regions, and they 
hypothesized that this binding would “open up” CagA, and thus reveal the residues 
required to interface with the T4SS.  I could test this hypothesis by deleting CagF 
and seeing if CagA will still interact with the T4SS, through either the BioID 
method, or with the CagT-FLAG construct.  
It is also important to determine how CagA can translocate through the 
T4SS, now that we have an idea of what part of that structure looks like. One 
possibility is that CagA may pass directly through the central pore visible within the 
core complex. Recently, 876 residues of the amino-terminus of CagA have been 
crystalized, revealing dimensions of 8 by 11 by 5.5 nm (48).  A structure of this 
size could conceivably fit through the ~10-nm pore of the core complex while still 
folded.  However, the mechanisms by which CagA enters host cells after 
translocation across the bacterial envelope remain a topic of inquiry.  It is 
presumed that the T4SS-associated pili assembled at the bacterium-host cell 
interface contribute to the entry of CagA into host cells (34, 49, 50).  And it has 
been suggested that binding of CagA to phosphatidylserine or integrins on the 
surface of host cells also may be important for entry into host cells (51, 52). 
Another question is to determine the orientation of the core complex within 
the bacterial membrane.  It is tempting to speculate that the stalk portion is 
oriented to the periplasm and inner membrane that CagA interacts with the 
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stalk.   Interestingly, there is cryotomography data of the L. pneumophila core 
complex in situ which shows that is has very similar dimensions as the cag T4SS 
core complex, as well as a long, stalk-like domain, and stalk-like domain points into 
the periplasm (58).  So, it is likely that the cag T4SS has a similar 
orientation.  However, it would be ideal to have experimental data to support this 
hypothesis.  Fortunately there are some tools at our disposal to answer this 
question.  Previous work in our lab optimized a protocol to biotinylate the surface 
exposed residues of outer membrane proteins in H. pylori.  I could use this same 
protocol, and then isolate the core complex and determine by immunoblotting 
which proteins are biotinylated.  I would then complement this approach by using 
streptavidin conjugated to nano gold particles to identify by EM which areas of the 
core complex are biotinylated.  If the stalk is labeled, it is likely that the stalk is 
surface exposed; if the stalk is not labeled and the ring like regions are labeled, 
this would suggest that the stalk is pointing into the periplasm.   
Finally there were some interesting results from IPs I performed from 
bacteria in contact with gastric epithelial cells that I was unable to follow 
up.  Namely, when we performed mass spec on the samples, we identified not only 
bacterial proteins also identified eukaryotic proteins that were enriched by the 
IP.  We recovered Par1b/MARK2, which has been previously identified as a 
binding partner of CagA (60).  We also recovered significant amounts of a “general 
transcription factor II (TFII-IB)” as well as both the S1008 and S100A9 subunits of 
the antimicrobial protein, calprotectin.  It is important to note that these interactions 
could either be between the core complex components or CagA; the eukaryotic 
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cells are lysed with the bacterial cells, and incubated together.  Since CagF is the 
protein I am directly pulling down, this interaction can either purify CagA alone, or 
CagA and the core complex.  To determine which proteins the eukaryotic proteins 
are interacting with, it would be vital to perform a glycerol gradient on the samples, 
and assess where the eukaryotic proteins co-migrate.  
However, both of these are intriguing results for different reasons.  The 
nuclear isoform of TFII-IB has been shown to suppress the expression of c-fos by 
binding to its promoter (61), while cagA positive strains will actually induce the 
expression of c-fos (62).  It is possible then, that CagA could be binding to TFII-IB, 
thus making it unable to repress expression of c-fos.  EMSA of TFII-IB with this 
promoter sequence either incubated with or without CagA could start to answer 
this question.   What is intriguing about the calprotectin result is that previous 
studies have shown that calprotectin actually lowers the activity of the cag T4SS 
(63).  Calprotectin could be directly binding the core complex, and somehow, 
suppressing its efficiency of formation, since the previous study assesses T4SS 
function through analysis of IL-8 induction and CagA translocation.   
There are a variety of directions for the study of the T4SS.  The focus can 
be on the actual mechanism of CagA translocation, others can elucidate the 
various protein interactions that make up the machinery of the T4SS and finally, 
there can also be focus on the interaction that the effector protein or the T4SS 
itself makes with host eukaryotic proteins.  Regardless of which avenue is chosen, 
all of these studies will provide important insights to a highly relevant virulence 
factor of the gastric pathogen H. pylori.  
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